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CHARACTERIZATION OF THE ADIPOGENIC DIFFERENTIATION 
POTENTIAL OF BONE MARROW AND ADIPOSE TISSUE-DERIVED 
MESENCHYMAL STEM CELLS AND DERMAL FIBROBLASTS 
SUMMARY 
Research of especially the past decade has pointed adipose tissue as a highly active endocrine organ 
rather than being an inert tissue. This also promoted investigations on the origins of adipocytes. In this 
context, the most important finding was the discovery of the adipose tissue-resident mesenchymal 
stem cells. However, it has been lately understood that these cells have a limited proliferative 
capacity, thus the idea occured that there should be other sources, feeding the tissue from non-adipose 
tissue resident progenitor cells. 
According to this statement, the principal aim of this master’s thesis was to understand the adipogenic 
differentiation potentials of two bone marrow (BM72 & BM78) and one adipose tissue (LA47) -
derived mesenchymal stem cell strains and a dermal fibroblast cell strain (DF24). For this purpose the 
relative expression levels of the adipogenic marker genes proliferator-activated receptor γ (PPARγ), 
perilipin, and adiponectin (ADPQ) were analyzed with qRT-PCR. Upon adipogenic induction, the 
expression profiles of marker genes were largely intensified in all MSCs from bone marrow or fat 
tissue, while expression was only rudimentary in dermal fibroblasts. The surprising finding at this part 
was gained by the comparison of the gene expression kinetics of the MSCs. Accordingly, the 
differences in expression between these cell strains mirrored an initial adaptation to the different 
environments or distinct inherent traits. This may point to a difference in the commitment stages of 
MSCs from bone marrow and adipose tissue, also allowing the discrimination of early progenitors and 
their progeny, the pre-adipocytes. 
For better understanding of the adipogenic differentiation potential of DF24 cells, they were analyzed 
by immunofluorescence staining in parallel to gene expression assays. Although the observed oil 
droplet formation or cell shape changes were indicative of adipogenesis, there was no definite proof to 
say that dermal fibroblasts initiate and proceed in true adipogenic differentiation.  
As other connective tissues, adipose tissue is structured by a sscaffold of extracellular matrix (ECM) 
which exerts signalling functions, too. At the last part of the thesis, different types of ECM proteins 
were examined for their influences on adipogenesis. Herein, promoting and mainteaning effects on 
adipogenic differentiation were found for collagen type I and fibronectin whereas collagen type IV 
and laminin proteins did not reveal any measurable effect. 
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KEMĐK ĐLĐĞĐ VE ADĐPOZ DOKU KÖKENLĐ MEZENKĐMAL KÖK 
HÜCRELERĐN VE DERMAL FĐBROBLASTLARIN ADĐPOJENĐK 
FARKLILAŞMA POTANSĐYELLERĐNĐN KARAKTERĐZE EDĐLMESĐ 
ÖZET 
Özellikle son on yılda yapılan çalışmalar, adipoz dokunun inert bir doku olmaktan çok, aktif bir 
endokrin organ olduğunu göstermektedir. Bu gelişmeler ise bilimcileri adipoz hücreleri olan 
adipositlerin kökenlerini araştırmaya yöneltmiştir. Bu bağlamda yapılan en önemli keşif, adipoz 
dokuda yerleşik olarak bulunan mezenkimal kök hücrelerin bulunmasıdır. Ancak bu hücrelerin kısıtlı 
çoğalma kapasiteleri sonradan anlaşılmıştır, dolayısıyla adipoz dokuyu dışarıdan besleyen, adipoz 
dokuda yerleşik olmayan ata hücrelerin bulunduğu hücresel kaynaklar fikri ortaya çıkmıştır. 
Belirtilen açıklamaya göre bu yüksek lisans tezinin birincil önceliği, kemik iliğinden (BM72 & 
BM78) ve adipoz dokudan (LA47) elde edilen mezenkimal kök hücrelerin ve dermal fibroblast 
(DF24) hücrelerinin adipojenik farklılaşma kapasitelerinin anlaşılmasıdır. Bu amaç için 3 tane marker 
gen (proliferator-activated receptor-γ (PPARγ), perilipin, and adiponectin (ADPQ)) ekspresyon 
dereceleri açısından karşılaştırmalı qRT-PCR tekniği ile analiz edilmişlerdir. Adipojenik uyarıma 
bağlı olarak mezenkimal kök hücrelerde, marker genlerin ekspresyonları yüksek oranda artmış, 
fibroblastlarda ise tam etkinleşmemiştir. Şaşırtıcı olan sonuç ise mezenkimal kök hücrelerin gen 
ekspresyon kinetiklerinin karşılaştırılmalarıyla bulunmuştur. Buna göre, ekspresyondaki değişiklikler 
bu hücre soylarının yeni çevrelere adaptasyon geliştirdikleri veya doğalarında farklı özellikler 
taşıdıklarını göstermektedir. Bu yüzden, yapılan buluş bu kök hücrelerin farklı adanmışlık 
seviyelerine sahip oldukları anlamına gelebilir ki, bu ise adipositlere farklılaşan hücrelerin ve onların 
atalarının ayırımı açısından anlamlı olabilir. 
Fibroblast hücreler, adipojenik farklılaşma kapasitelerinin daha iyi anlaşılması için, gen ekspresyon 
çalışmalarına ek olarak immünofloresans boyama ile analiz edilmişlerdir. Bu hücrelerin yağ parçacık 
yapılarına ve hücre şekillerine dair anlamlı bulgular elde edilmiş olsa da, fibroblastların bu farklılaşma 
türüne başlayıp devam ettiklerini net olarak söylememize olanak sağlayacak bulgulara rastlanılamıştır. 
Diğer bağ doku üyeleri gibi, adipoz dokuda da ekstrasellüler matriks yapısal bir iskele görevi görür. 
Bu ise dokudaki sinyalizasyon olayları açısından gereklidir. Tezin bu son aşamasında, farklı türdeki 
ekstrasellüler matriks proteinleri, adipojenik farklılaşma üzerindeki etkileri açısından analiz 
edilmişlerdir. Bu bağlamda, kollajen tip I’in ve fibronektinin adipojenik farklılaşmayı arttırıcı ve 
koruyucu etkilerine rastlanılırken, kollajen tip IV ve laminin nötral bir etki göstermişlerdir. 
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1. INTRODUCTION 
Adipose tissue is an important member of connective tissues in humans. It serves as 
an energy storage in the body, dampens mechanical impacts of outside world and 
provides thermal insulation. However, studies especially in the last decade have 
changed our beliefs about this tissue. The regulatory roles of adipocyte cells on the 
energy metabolism of the body, and adipocytes’ immunomodulatory nature are being 
better understood everyday [1]. 
Severe obesity, where adipose tissue tends to expand in the organism, is considered 
as a much more insidious condition or disease than previously believed. It is an 
important defect which generally decreases the quality of life of an individual. 
Today, this excessive adipose tissue expansion is recognized as an important risk 
factor for other common disorders such as diabetes, various cardiovascular diseases, 
cancer and metabolic syndrome [2]. 
These two mentioned facts underline the importance of adipose biology as research 
area for human health care. Adipocytes, the main adipose tissue cell population, play 
a crucial role for formation of adipose tissue. Although there is vast amount of 
literature on the molecular details of these cells, the unknowns, still, by far exceed 
what is known. The origins of adipocytes is currently one of the most controversial 
issue. Yet which cell types give rise to adipocytes is not completely clear. The 
overcrowded and intricated nature of these tissues complicates the entire 
understanding of adipocyte origins. 
Connective tissues consist highly of the extracellular matrix (ECM). Some common 
ECM proteins (such as collagen type I, collagen type IV, fibronectin, laminin that 
were studied in this thesis) in skin ECM layers were examined for their  influence on 
adipogenic differentiation. Accordingly, bone marrow-derived mesenchymal stem 
cells were cultured on surfaces coated by distinct ECM proteins and analyzed for 
their adipogenic gene expressions. 
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1.1 Aim of the study 
The aim of this study was to investigate the adipogenic differentiation potentials of 
mesenchymal stem cells derived from bone marrow and fat tissue in comparison to 
dermal fibroblasts. For this purpose, gene expressions with special focus on 
adipogenic marker genes were analyzed in mesenchymal stem cells and fibroblasts 
subjected before and after induction to adipogenic differentiation in cell cultures. We 
examined the adipogenic potential of dermal fibroblasts using fluorescence staining 
and microscopy, in order to consolidate previously found relative gene expression 
data of the sample. At the final stage of the project, we aimed to study the influence 
of ECM protein coatings on adipogenic differentiation through the analysis of 
relative PPARγ, perilipin and adiponectin gene expression. 
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2. ADIPOSE TISSUE AND ADIPOCYTES 
2.1 The Importance of Adipose Tissue 
During evolution, different cell types have taken associative tasks and consequently 
they have given rise to structured tissues. Organs and systems are major parts of 
organisms which are developed in time by tissues that have been working in 
harmony. Human is a well developed mammalian organism which has come into 
existence with the relevant associations of organs and systems [3]. Therefore, 
anatomical and physiological unison of tissues better be considered as a very basic, 
important factor of a healthy organism. 
Diseases impair normal functioning of tissues. Today, we are able to fight against the 
diseases with the contributions of a more profound understanding of physiological 
and anatomical basics of organs and systems. And this manner is achieved by the 
better understandings of the tissues which are structured by specialized cells and 
their products. Adipose tissue is an important tissue for the survival of the organism 
[5]. It associates with almost all units of the body. It contributes to the structures of 
many organs including the surrounding of intestines, muscles, and liver. It works 
together with endocrine system and digestive system. It provides insulation for the 
body and a cushion against mechanical impacts of the environment. Besides that, 
adipose tissue is the most important energy reservoir for the organism [6]. 
2.1.1 Disorders associated with adipose tissue 
2.1.1.1 Human diseases 
Obesity is a condition which recently was gaining importance as a generalized 
disease with large impact on human health. It is described as higher amount of 
weight exceeding the normal standards for the human body. But this overweight 
situation is accounted by the total amount of fat tissue, not the body mass per se. 
4 
 
Though obesity reduces the life quality, most importantly it mediates the occurence 
of various other disorders. 
An obese individual exhibits an excessive increase in the number of adiposite cells 
[8]. The reason of obesity can be either environmental and genetical. Today many 
mutations are known to be related with obesity throughout the human genome [9]. 
Adverse effects of obesity on health are generally related to metabolic irregularities 
which create cardiovascular risk factors [10]. Impaired glucose tolerence is one of 
the mainly considered metabolic defects in this respect [11]. Today, the sum of these 
risk factors is called “metabolic syndrome”. This syndrome includes disabilities such 
as insulin resistance, abdominal obesity and hypertension [12]. 
Some clinical trials have reported that in obese individuals incidence of malignancy 
and metastasis rates are higher than in normal individuals [16-18]. One explanation is 
that adipocytes reaching a certain size slows down their metabolism to store more 
lipids inside. Especially the decrease of adiponectin causes regional 
neovascularization which is needed for expansion of adipose mass. However, this 
incident unwittingly creates the relevant status for tumor neovascularization [19]. 
Thus plenty of cases have been reported where certain cancers correlated with 
overexpression of a variety of adipose tissue-derived molecules [20]. 
2.1.1.2 Disease models in transgenic animals 
Problems associated with adipose tissue should not be only considered just as a result 
of over production of adipocytes. There are intriguing results from transgenic animal 
studies done in several laboratories. Adiponectin for example is an important 
regulatory molecule which is expressed only by white adipose tissue [13]. This 
molecule is involved in energy metabolism of the organism. A research has reported 
that knock-out mice fed with a normal diet do not show significant differences 
compaired to wild-type, however, they developed severe insulin resistance when fed 
with sucrose and oil based diet. This insulin resistance has been observed either in 
obese mice or lipoatrophic mice. Deterioration of insulin mediated mechanisms lead 
to plenty of disorders such as diabetes, hyperglycemia and liver enlargement 
(hepatomegaly) [15]. 
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2.2 Adipose Tissue 
2.2.1 Adipose tissue - a specialized form of connective tissues 
In histology there are four classified tissue types for mammals: Epithelial, muscular, 
nervous, and connective tissue (Fig. 2.1). Connective tissue provides shape and 
structure of the body and keeps its units and organs together. It consists of a 
comprehensive part of extracellular matrix. The most abundant protein in connective 
tissues is type-I collagen which generates 25% of the total protein mass in mammals. 
 
Figure 2.1: Four main classes of human body tissues (connective tissues - 
www.hawaiianshirtray.com). 
Today, still the term “connective” is used to address this tissue. However, current 
knowledge over these body units tells us that they have additional significant roles 
for the body far beyond providing scaffolds or merging structures. Adipose tissue is a 
quite distinct non-fibrous example of connective tissue, where its most important 
regulatory role concerns endocrinological tasks [22]. 
Adipose tissue is generally formed by the cells that have the capability to store high 
amounts of triglycerides (fats) [23]. Even today, despite the recognition of adipose 
tissue as such centuries ago, its secrets need to be fully elucidated yet. In humans, it 
is generally located beneath the skin and also around the organs, yellow bone 
marrow in long bones, breasts and hips [24]. The adipose tissue under the skin is 
called “subcutaneous fat” (SF), whereas surrounding the organs it is called “visceral 
fat” (VF) [25]. There are some similarities but also differences between SF and VF. 
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About 80% of the total adipose tissue molecules are triglycerides (oil). The resident 
adipocytes are specialized for storing oil and the mature cell usually carries a single 
large oil drop in its cytoplasm [26]. This oil drop pushes all cell organelles outwards 
the plasma membrane causing overhang structures around the cell (Fig. 2.2). A 
significant layer of extracellular matrix surrounds the cells. The adipose tissues 
which contain one oil drop adipocytes, appear in white color to our eyes. Thus, these 
are called “white adipose tissues” (WATs) in histology [27]. Brown adipose tissues 
(BATs) are the only alternatives of WATs. 
 
Figure 2.2: Mature unilocular human adipocyte (bio107, University of Connecticut). 
2.2.2 Distribution of adipose tissue in the body 
Adipose tissues are further classified as VF or SF according to their locations. VFs 
are found within the abdominal cavity and they usually surround the organs. 
Epicardial fat which surrounding the heart is such an example of VF. Accumulation 
of VF is known as central obesity and it has a direct relation with cardiovascular 
diseases [28]. Moreover, relationships are found to other diseases such as diabetes 
and insulin resistance [29]. SF is settled under the skin in the hypodermis layer. 
These fat deposits are thought to have protective function against obesity-linked 
disorders in contrast to VFs [28]. 
Considering general human anatomy, male body shape is evident with the 
accumulation of total body mass at the upper-segment. In women, total body mass 
trends to accumulate downwards in the body. This difference occurs due to the 
endocrinological disparities between men and women (Fig. 2.3). Furthermore, 
hormonal changes in women after menopause can have an effect on the way how a 
woman is gaining weight [29]. 
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Figure 2.3: Body fat distribution of human. Due to the genetical background and 
environmental factors, body fat distribution varies. However, this is 
mostly affected by hormonal conditions. Body shape of a woman can 
change after menopause with the new hormonal regulations 
(www.emedicinehealth.com). 
The distribution of adipose tissue in the body is mostly genetically determined [30]. 
Life style including exercise profile and food consumption habits contribute to the 
quantity of the adipose tissues, but not their distribution. In a person’s body who 
consumes a lot of food, more fat storage tends to increase in adipocytes. As a result, 
there occurs an increase in the size of the cells and after a point, these cells begin to 
multiply. The adipocytes in the body which show susceptibility to grow and multiply 
are genetically determined. However, it is still unclear that what factors control 
where does a person gain the weight. Abnormal adipose tissue expansion occurs in 
the body in the case of obesity. Panniculus is a significant example of abnormal SFs 
where the adipose tissue enlarges in the tummy [31]. However, it has to be noted that 
the excessive weight gain does not necessarily happen in subcutaneous tissues. Even 
though the knowledge we have about the development of obesity increases every 
passing day, the exact picture is far from being clear. Open questions are which cells 
give rise to adipose tissues? What are the regulatory mechanisms? The answers for 
these questions are important issues in adipose biology, which still wait for us to be 
discovered. 
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2.2.3 Functions of adipose tissue 
The most basic functions of adipose tissues were emphasized as being a thermal 
insulator, energy storage and a mechanical support for the body. In the organism, an 
increasing requirement for energy triggers lipase enzymes to hydrolyze the 
triglycerides stored in adipose tissues. The hydrolysis of triglycerides releases free 
fatty acids. Adipocytes excrete these fatty acids into the blood stream and by the 
circulation these metabolites are transported to muscles and the heart [32]. The fat 
decomposition and fatty acid release into the blood is known as lipolysis, whereas 
the reverse process, oil storage is called lipogenesis. Insulin triggers lipogenesis in 
the organsim [32]. Today, in addition to the given characteristics, adipose tissue has 
been accepted as an important endocrine organ which plays a role for insulin 
sensitivity, in inflammatory reactions, energy homeostasis, and food consumption 
behaviors [33]. 
Several molecules have been identified that are synthesized in adipose tissue acting 
as hormones in the organism (Fig. 2.4). These molecules are generally called 
adipose-derived hormones, while signalling molecules from adipose tissue that have 
immunomodulating properties are collectively termed adipokines (see cytokine) [34]. 
 
Figure 2.4: Important factors and functions of adipocytes (modified [166]). 
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The most well known adipose-derived hormones are adiponectin, leptin, resistin and 
estradiol. These hormones work generally in energy metabolism, and are directly 
associated with obesity and type-II diabetes. Adipose tissue has been first recognized 
as an endocrine organ after the discovery of leptin functions [35]. The appetite 
suppressant attribution is leptin’s best-known feature. Estradiol is a sex hormone that 
is very important for gender differentiation in humans [36]. The name resistin, was 
given to the protein for the discovery that its injection in mice gave rise to insulin 
resistance [37]. In obesity, increased serum levels of resistin are found. Adiponectin 
is a very identified adipose-derived hormone which is secreted abundatly into the 
blood by adipocytes and which is crucial for glucose metabolism and fatty-acid 
catabolism [38]. 
Among adipokines secreted from adipose tissue, chemerin in particular inhibits cell 
growth but also cellular differentiation. David Segal and colleagues reported lower 
expression of chemerin in pre-adipocytes whereas after the differentiation chemerin 
synthesis increased [39]. Among the other important adipokines, tumor necrosis 
factor – alpha (TNF-α), Interleukin 6 (IL-6), and monocyte chemoattractant protein 1 
can be given.  
Last not least, adipose tissue-derived macrophages play an active role in the 
organism. In obesity, excessive accumulation of macrophages in adipose tissue has 
been demonstrated [40]. Though by now, adipose tissue is commonly appreciated as 
an endocrine organ and too many mysteries are waiting us to be discovered yet. 
2.2.4 Adipose tissue structure 
The discrimination between WAT and BAT is based on the features of the 
adipocytes as well as the tissue structures [27]. Composing 20-25% of total body 
weight of a healthy human, WAT is the main energy storage in the adult organism. 
While adipocytes represent the main cell population of WATs, there are also 
macrophages, fibroblasts and endothelial cells in this tissue. In addition, WAT 
contains a compact extracellular matrix and many small blood vessels. WATs can 
have both subcutanaeous or visceral location. 
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On the other hand, BAT is known as newborns’ fat [41]. Thus, it is found in 
abundance in neonates but also in hibernating mammals. The reason for this is that it 
acts as heatgenerator in the organism. This is accomplished by a high number 
mitochondria in the resident adipocytes (Fig. 2.5) [42]. 
 
Figure 2.5: Brown adipocyte histology and UCP1 (mitochondrial proton carrier 
protein) function. (A) Morphological comparison of white and brown 
adipocytes. (B) Photomicrograph of mouse BAT. Nu—nucleus, L—
lipid droplets, Nv—nerve fiber. (C) Electron micrograph of a brown 
adipocyte with abundant mitochondria that are labeled for UCP1. 
Arrows point to UCP1 labeling (immunogold, 14 nm) [42]. 
While WAT adipocytes harbor one single large oil drop, BAT adipocytes contain 
many small oil droplets scattered in the cytoplasm. Another significant difference 
between BATs with WATs is that BATs contain a much higher number of capillary 
blood vessels. Eventually, regarding the given properties, this adipose tissues get its 
brown color. Suprisingly, BATs have kept disappearing during the human 
evolutionary process. Today, the fat content of BATs is even lower than 0,1% of 
total body fat in adult humans. 
The main element of adipose tissues is fat storing adipocytes. In addition to those 
cells, stromal-vascular cells are also found in adipose tissues such as macrophages, 
leukocytes, pre-adipocytes, and fibroblasts. The same type of adipose tissue might 
exhibit different activities in different regions of the body. This may rely on the 
properties of the adipocytes or the other cell types in the particular adipose tissues 
[43]. 
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Adipose tissue’s size is a consequence of the total number of adipocytes and their 
cell mass, therefore it can increase by proliferation of adipocytes or by lipid 
accumulation. Either one of these activities can dominate at different stages of an 
individual’s lifespan. Thus, neonates are relatively fat posessing a dense and widely 
dispersed adipose tissues [44]. This is a result of the adipose development at late 
pregnancy, however, actual mechanism is not clear yet. 
2.3 Adipocytes 
The name, adipocyte is given to the cells storing high amounts of fat [45] which have 
a largely spherical shape. As mentioned above two types, WAT and BAT adipocytes 
can be distinguished. The majority of the fat cells in the body are WAT adipocytes, 
typically containing a single large oil drop in the cytoplasm and being widely 
distributed throughout the body. Contrarily, BAT adipocytes have a more limited 
distribution and their role is to  generate heat for the organism by oxidizing fatty 
acids [42]. They have many small oil droplets in their cytoplasm. These oil droplets 
are found coated by perilipin proteins inside the cell [32] which happens to protect 
the lipids from lipase activity. 
Concerning still another classification, the distinction between subcutaneous adipose 
tissues (SAT) and visceral adipose tissues (VAT) is not just based on their location. 
For example, lipolysis and fatty acid turnover are seen more frequent in VAT 
adipocytes [46]. Furthermore, it has been observed that VAT adipocytes produce 
more IL-6 than SAT adipocytes. IL-6 is an inflammatory adipokine which also 
suppresses the insulin response in the organism [47]. On the other hand, SAT 
adipocytes produce more leptin and adiponectin and these two factors intensify the 
insulin sensitivity. A particularly striking is that adiponectins are very specific 
molecules only synthesized by adipocytes but their expression differs in VAT and 
SAT adipocytes [38]. 
The question is the structural and functional differences between VAT and SAT 
adipocytes are due to distinct precursor cells, i.e. pre-adipocyte originated from 
different tissues or body regions or reflect specific differentiation traits influenced by 
region-specific growth and differentiation factors. 
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2.3.1 The origin of adipocytes 
Today, emerging technologies and increasing general wealth allow us to reach easily 
to higher amounts of nutrients than in the past. However, this is creating serious 
health problems since society does not change as quick as the technologies, in 
adapting to these new conditions and life styles. As a result of this ambiguous 
progression, less moving and consuming more and unnatural foods have become 
inevitable reasons of obesity [49]. 
Obesity is an insidious disease; it causes many other diseases in the organism [8]. 
Increasing cases of obesity and related health problems have propelled studies on the 
cause of obesity. This has revealed that adipose tissue has important regulative 
functions beyond being just energy storage or mechanical support, consequently 
raising questions for the origins and development of adipocytes. 
1. What triggers the formation of adipose tissue? 
2. How does adipose tissue come into existence? 
3. How adipose tissue formation can be reduced without imparing general 
health? 
To answer these questions we need to understand the morphological and 
physiological features of adipose tissues in the context of the origin of adipocytes 
which, as stated before, are the main components. Question is that do specialized 
stem or precursor cells exist like all the other cell and tissue types in the organism, 
being responsible for self-renewal and repair of those structures. 
During the development, the mechanism of commitment of embryonic stem cell 
precursors to adipocyte lineages is still unclear. WAT formation displays differences 
among different species but it begins before birth in all mammals and thus humans 
are born with relatively well developed adipose tissue. After birth, WATs experience 
a rapid expansion depending on the number of adipocytes [27] but this process and 
the factors involved are not well understood yet. Nutrient stimulation of adipose 
tissue expansion is also a matter still under investigation [44]. However, today 
concepts emerged about pre-adipocytes or precursor cells which have the potential 
for adipogenic differentiation. Currently the nature of those cells is investigated 
together with regulatory mechanisms effecting cellular differentiation. 
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A large part of such studies implies that certain embryonic stem cells which have 
capacity to differentiate into mesodermal cell types (osteoblasts, adipocytes, 
myocytes and chondroblasts), give rise to adipocyte lineages during development 
[50]. This means that some multipotential stem cells are fixed in mesodermal 
pathways [51]. On the other hand, there is rising evidence that a common pool of 
bone marrow stromal cells can differentiate into adipocytes or osteoblasts among 
other cell types under respective stimulation [52]. 
Do all adipocytes come from the same mesodermal origin? An important proposition 
is that adipocyte progenitors derive from cells located in vascular network, which 
constitute a pool of resident pre-adipocytes capable for self-renewal [53]. These cells 
give rise to new adipocytes in stead of the dead ones, and respresent a source for the 
expansion of adipose tissue. However, this is still controversial and the cells admitted 
as adipose-lineage committed pre-adipocytes have not been clearly defined. There 
are mainly two concerns, firstly a specific marker has not been discovered yet to 
distinguish the progenitors from other stromal cells and secondly, there are extremely 
heterogeneous cell populations in these regions. 
One of the most important discoveries about adipocyte progenitors were made by 
Friedman and colleagues [54]. By fractionating adipose stroma cells using sequential 
flow cytometry fractionation and established stem cell markers , they were able to 
isolate adipocyte progenitors. One cell lineage, being CD29+, CD34+, Sca-1+, 
CD24+, retained the ability of adiponegic differentiation. This cell population could 
also differentiate into bone, cartilage, and muscle cells. Thus, a great premise of this 
study was the discovery of adipose-resident pre-adipocyte progenitors. Another 
important contribution on this subject was made by Jensen and colleagues [55]. 
According to their work on, obesity, increasing adiposity in humans leads to a 
decrease in the number of committed subcutaneous pre-adipocytes. From these 
studies the conclusion can be drawn that: adipose tissues contain resident-adipocyte 
progenitors indeed. However, these cells have a limited proliferative capacity which 
requires refreshment from non-adipose tissue resident resources. 
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2.3.1.1 The contribution of non-adipose tissue resident progenitors to 
adipogenesis 
After the discovery of the limited proliferation capacity of progenitor cells resident in 
adipose tissue, cells contributing to WAT formation became a major subject of 
research. Most probable candidates are bone marrow tissue progenitors [56]. Bone 
marrow is a tissue very rich in mesenchymal and hematopoietic stem cells. These 
distinct stem cell populations are multipotent having both a wide differentiation 
potential. Usually mesenchymal stem cells seem not to leave this site while 
adipocytes are also present at there. On the other hand, some of those hematopoitec 
stem cells which have mesenchymal characteristics, apperently leave the marrow and 
settling in other tissues where they might convert into adipocytes [57]. Accordingly, 
marrow stem cells are the primary progenitor candidates. 
This has been demonstrated by two seperate studies on mice and rats. In both cases, 
bone marrow labelled with green fluorescence protein (GFP) was transplanted into 
wild-type animals [58,59] which allowed to detect and trace GFP expressing 
adipocytes derived from the marrow graft in host adipose tissue by fluorescence 
microscopy. In another related investigation, Makio Ogawa and colleagues 
demonstrated that also hematopoietic stem cells can develop into adipocytes [57]. 
However, similar marrow transplantation experiments by Gou Young Koh and 
colleagues started a hard debate about the validity of this hypothesis [60]. Their aim 
was to follow the fate of the bone-marrow-derived circulating progenitor cells 
(BMDCPCs) and determine their adipogenic potential in vivo. But herein no 
unilocular or multilocular development could be observed among the cells which had 
migrated from bone marrow to adipose tissue. Instead, the majority of the resident 
BMDCPCs had become phagocytic cells, showing a weak multilocular phenotype. 
Thus, they did not express uncoupling protein 1 (UCP1) which is a brown adipocyte 
marker, whereas some macrophage surface markers were detected. 
As mentioned earlier, Makio Ogawa and colleagues demonstrated the adipogenic 
potential of hematopoietic stem cells [57]. Psilas and colleagues have carried this 
investigation one step further by comparing mesenchymal and hematopoietic 
(myeloid) progenitor cells [61]. They have done GFP labelled bone marrow 
reconstitution in mice which are restricted to express LacZ in only hematopoietic 
cells. Since the vast majority of adipocytes detected in the animals were found 
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LacZ+, this advocates for that bone marrow-derived adipocytes descend from 
hematopoietic stem cells. In another study, adipocyte progenitors which expressed 
neither hematopoietic nor myeloid markers (CD45 – CD11b) were found, which may 
point to circulating fibroblasts [62]. Finally, it has to be mentioned that bone 
marrow-derived progenitors were frequently in VATs but very rarely in SATs in 
bone marrow reconstitution studies on mice. 
In summary, mesenchymal stem cells seem to be the primary pre-adipocyte 
progenitor candidates according to the majority of published work. On the other 
hand, some studies suggest that hematopoietic stem cells from bone marrow might 
substantially contribute to adipogenesis. Still not fully established is the adipogenic 
capacity of fibroblastic or stromal cells, though their strong migratory phenotype and 
their occurrence in adipose tissues make them better progenitor candidates than their 
hematopoietic fellows. 
2.3.2 A mysterious subject – Adipocyte Progenitors 
In human development, there is a delicate balance between cell proliferation and 
differentiation, as a strict rule differentiating cell not being able to engage 
proliferation at the same time [63]. In essence, cell differentiation means to acquire a 
more specialized state than the progenitor cell. With initiation of embryonic 
development, cells begin to differentiate to form distinct tissues. However, during the 
life of the organism, major pools of tissue or organ specific progenitor cells are 
needed which are called committed stem cells. 
The Latin word “Genesis” has the meaning of both initiation and creation. In 
biology, different types of differentiation are called with the name of the ultimate cell  
combined with the suffix “genesis”. Adipogenesis for example describes the process 
where cells differentiate eventually into adipocytes. 
Adipocytes of BAT begin to evolve from mesoderm in the second half of pregnancy 
[44], while after birth, an increase in WATs occurs in individuals. It has been thought 
that pre-adipocyte progenitors begin to take positions in the organism in this 
timeline. As outlined  in chapter “The Origin of Adipocytes”, mesenchymal stem 
cells are commonly regarded as the primary progenitor cells for the mature 
adipocytes. Fibroblasts, with some features and a strong kinship to mesenchymal 
stem cells, are also considered as additional candidates. 
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2.3.2.1 Mesenchymal Stem Cells (MSCs) 
Mesoderm is one of the three main germ cell layers of mammalian embryos seen at 
very early stages. During development, mesoderm forms different tissues which give 
rise to new organs and compartments in the body. The mesenchyme being, one of 
these embryonic tissues, also known as loose connective tissue [64], constitutes a 
large part of circulatory system including heart and major blood vessels as well as 
bone, cartilage, the dermis in skin, and adipose tissues. The mesenchymal stem cells 
(MSCs) are rooted from the mesenchymal layer. They are non-hematopoietic 
progenitor cells which are found in virtually all adult tissues. It is believed that they 
have an uncommitted state and enhanced proliferative potential [65]. 
Musculoskeletal tissues such as cartilage, bone, muscle, ligaments, and tendons but 
also adipose tissue are composed by descendants of MSCs. This type of progenitors 
is collectively called multipotent stem cells [66]. 
Similar to fibroblasts, MSCs are thin elongated cells with a small cell body (Fig. 
2.6). They contain a wide circular nucleus and a prominent nucleolus which serves as 
cell information center. In cell reproduction and differentiation the nucleolus plays a 
significant effects by regulation of gene expression. This may explain the marked 
appearance of the nucleolus in MSCs. Commonly, MSCs change their cell shape as a 
result of differentiation. 
 
Figure 2.6: Human bone marrow-derived mesenchymal stem cell culture. Image was 
taken after postconfluency under 100x magnification. 
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The duties of MSCs vary. Their first and most important task is serving as 
progenitors in the organism. Thus, they give life to a variety of cells with distinct 
differentiation properties. For this and their regenerative features, MSCs are also 
essential in tissue repair (wound healing) [67], which is further fostered by their role 
in angiogenesis [68]. Based on that, MSCs are promising candidates for the treatment 
of chronic wounds. As a member of connective tissues, MSCs might enhance or 
improve functions of other cells in their micro-environment. As one example, 
Majumdar and colleagues had shown that MSCs are the stromal cells which support 
hematopoiesis [69]. They substantiated this hypothesis by providing extracellular 
matrix and specific signal molecules to cells which are committed to hematopoiesis. 
Today, one of the most focused tasks is the immunomodulatory activity of MSCs. 
First, their T-cell proliferation inhibiting properties had been discovered, but they 
showed similar effects also on B cells, natural killer cells, and dendritic cells [70]. 
These features imply  that MSCs could be useful as immunosuppressors in immune-
mediated diseases and after organ transplantation. 
In 1966, Friedenstein and colleagues defined mesenchymal stem cells from bone 
marrow as colony-forming unit (CFU) fibroblast-like cells for the first time [71]. 
They also demonstrated that MSCs undergo osteogenic differentiation. By the 
passage of time, the potential of MSCs to differentiate into other tissues has been 
discovered, including cartilage, bone, fat, muscle, tendon, and hematopoiesis 
supporting marrow stromal cells. Today, several MSC specific surface markers are 
known which are not present in hematopoietic stem cells [52], though they can be 
also expressed by certain other cell types. As stated previously, the lack of markers 
to distinguish the adipocyte progenitors from stromal cells have not been discovered 
and likewise also no markers to distinguish MSCs from other cells in their 
environment. Typically, MSCs exist with densely packed groups of other cell types. 
Collectively, this illustrates how difficult processes are to isolate MSCs from 
humans. 
 
 
 
 
18 
 
Mesenchymal Stem Cell Sources in the Organism 
In humans, embryonic stem cells are the most advanced cells with their great 
differentiation capacity. In different stages of development, stem cells are 
reprogrammed and as a result of this, changes occur in their differentiation 
capacities. For instance, MSCs which are isolated from a 30 years old individual’s 
bone marrow are different from the MSCs which are isolated from a newborn’s 
umbilical cord with their differentiation capacity. This difference is related to the 
ages of the cells, the factors they were exposed and their commitment levels. This 
distinction is supposed to be taken into consideration when thinking about MSC 
sources of the organism. The best studied source in an adult individual is bone 
marrow. Umbilical cord tissue and umbilical cord blood are also well known sources 
of MSCs [72]. Nowadays, isolation of MSCs from compartments such as adipose, 
muscle, dermis, trabecular bone, deciduous teeth, articular cartilage and periosteum 
has been known. However, MSCs isolated from different compartments can exhibit 
different behaviors [73]. 
One of the most richest MSC sources is bone marrow in humans. However, only 
0,001 to 0,01% of the total number of the cells which carry nucleus are just MSCs in 
this environment. This is a reasonable diagnos for two reasons: 
1. MSCs are cells with enhanced self-renewal and proliferation capacity. 
Therefore, stimulation of MSCs for proliferation in cases of need is more 
acceptable rather than storing them in high amounts. MSCs are mostly found 
in G0 stage in vivo [74]. 
2. The tissues structured by mesenchymal stem cells show relatively slow 
turnover rates; for example, blood tissue is much more active than bone 
tissue. Thus, the existence of hematopoietic stem cells which give rise to 
blood cells in much higher numbers is a normal status. 
The discovery of immunomodulatory properties of MSCs, provides important clues 
about their origins. Recent findings have shown the occurence of MSCs as pericytes 
around wound areas [75]. Pericytes are relatively undifferentiated cells which secrete 
large quantities of immunomodulatory and immunotrophic factors in wound regions. 
These factors are very important for wound healing and angiogenesis. In addition, 
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their capacity to form fibroblasts, macrophages and smooth muscle cells has been 
discovered. This finding opens another subject to debate. 
Different cells are found in different stages of differentiation. For example, pericytes 
are found between MSCs and fibroblasts up their differentiation stages. This is 
actually an imprecise but a true proposition. As discussed before, adipose tissue 
contains MSCs and fat-derived MSCs is an accepted fact. On the other hand, adipose 
tissue also contains fibroblasts. Regarding the differentiation stage hypothesis, 
fibroblasts are thought as terminally differentiated cells in the organism. However, as 
mentioned before, there are few examples which defend the fact that fibroblasts can 
differentiate. Based on these findings, can we tell “pre-adipocyte progenitor cells” to 
fibroblasts? 
2.3.2.2 Fibroblast – a major member of skin 
Human skin consists of two main layers. These are “epidermis” which is the outer 
surface of human skin and “dermis”, the layer beneath [76]. Epidermis is originated 
from ectodermal layers. 95% of the total cell populations are keratinocytes in 
epidermis. Apart from keratinocytes, epidermis contains melanocytes, Langerhan 
cells, Merkel cells and some other sense cells. Inflammatory functions are performed 
in this layer but the main task of epidermis is protecting the organism from effects of 
outer world. Epidermis performs its protection duty with the barrier formed by 
keratinocytes. These cells are capable to produce high amounts of extracellular 
matrix. They are originated from ectoderm layer. There are few recent studies 
reported the existence of keratinocyte stem cells in body [77]. Today, these stem 
cells are investigated to verify their existence and one step further, their usage as 
therapeutic agents. 
The discovery of transdifferentiation skills of fibroblasts is also a very new matter in 
hand. Dermis is the layer located beneath epidermis. It possesses an abundant 
collagen content. It consists of two main compartments; papillary and reticular. 
These two compartments vary regarding their fibrillar content; papillary is a loose 
tissue whereas reticular is tighter. 
Dermis tissue is very rich of collagen proteins. There are also other fibrillar proteins 
apart from collagens which give the flexibility to the tissue. Moreover, there exists a 
very dense extrafibrillar matrix in dermis. This matrix includes water, proteoglycans 
20 
 
and glycoproteins. Dermis contains 3 types of cells: Macrophages, adipocytes and 
fibroblasts; the main cell population is fibroblasts. 
Fibroblasts are the most abundant cells in connective tissues. They have an advanced 
capacity to produce extracellular matrix. They get activated during skin growth or the 
cases of skin wounds. According to their status or locations, they might exhibit 
different phenotypes. This becomes very evident in their cell shapes [78]. They are 
generally spindle-shaped cells. However, fibroblasts can take a more rounded shape 
when they are activated in a wound case. Furthermore, amount of rough endoplasmic 
reticulum is much higher at their activated states [79]. This is very meaningful 
finding because since fibroblasts are primarily responsible for wound healing and 
extracellular matrix production, it is a neccessity to have more rough endoplasmic 
reticulum regarding secretory pathways. Fibroblasts are very durable cell types with 
faster growth rates and longer life-spans. 
Can Fibroblasts Differentiate? 
Fibroblasts are originated from mesenchyme layer during embryonic development. 
Thus, they are not relatives of epidermal cells. However, there is “epithelial-
mesenchymal transition hypothesis” (EMT) in literature [80]. This situation is 
characterized with loss of cellular adhesion, inhibition of E-cadherin expression and 
cell mobility increase in the cells. This process has very similar parts with invasion 
of cancer cells [81]. EMT is an important process for mesoderm formation during 
embryonic development. In adults, EMT was observed in stomach epithelium [82]. 
On the other hand, there are some “mesenchymal-epithelial transition” (MET) cases 
in literature [83]. MET indicates us that in appropriate cases, mesodermal originated 
fibroblasts might contribute to the formation of epithelia. This is a very important 
and interesting situation, because fibroblasts had been always considered as 
terminally differentiated cells [84]. 
Fibroblasts are located in dermis tissue with macrophages and adipocytes. These 
cells have a common ancestor. Moreover, fibroblasts are very similar in shape with 
MSCs. All these given data lead us to investigate differentiation skills of fibroblasts 
to adipocytes, osteoblasts and chondroblasts. The obtained results are very diverse. 
Yilin Cao and colleagues examined dermal fibroblasts about their differentiation 
potentials [84]. They cultivate the cells in vitro and treat them with different 
mediums for different differentiations. 6,4% of the cells showed all types of 
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differentiations, whereas 19,1 of the cells showed 2 kinds of the differentiations and 
10,6% of the cells showed just one kind of differentiation. However, 63,9 of the total 
cells showed no differentiation ability. In addition, it has been reported that 1/3 of the 
tripotent cells (2,1% of total cells) also performed neurogenic and hepatogenic 
differentiation; this high transdifferentiation potential for fibroblasts is very thought 
provoking. But still, just 36,1% of the cells realized differentiation in the essay and 
this is a very small rate to talk about differentiation for a cell lineage. However, that 
is a fact that gives us clues about differentiation potentials of fibroblasts. 
These findings have generated questions about the relationship between fibroblasts 
and adipocytes. The presence of fibroblasts in adipose tissue, and per contra, 
adipocytes in dermis layer is known. Besides, fibroblasts are in direct interactions 
with MSCs which are the cells forming adipocytes. In the case of wounds on body, 
these two cell types work together. A recent study of fibroblasts revealed that if they 
are cultivated with MSCs, their proliferation and migration skills tend to increase 
[85]. Are they also in relation with fat-derived MSCs in vivo? Do they contribute to 
adipogenesis in the body? If they are, how do they contribute? 
Cells of connective tissues are in close and dense relations with their environments. 
Extracellular matrix compositions directly effect on the behaviors of the cells. The 
cells determined for adipogenic differentiation are usually found in a dense layer of 
extracellular matrix. Very different fibrillar proteins can be found in this layer, and 
this may affect the behaviors of progenitor cells. Therefore, an indirect influence of 
fibroblasts over adipogenesis can be mentioned since they are the main cell types 
forming extracellular matrix in connective tissues. In fact, a direct involvement to 
adipogenesis can be told for fibroblasts. The research which Giulio Alessandri and 
colleagues conducted has revealed that dermal fibroblasts have similar phenotypic 
features and differentiation potentials with fat-derived MSCs [86]. Accordingly, they 
shared some similar phenotypic profiles and displayed similar morphological 
appearance and growth rates. Moreover, they reported that both cell types which 
express mesenchymal markers, had adipogenic differentiation. This study is one of 
the rarest studies defending fibroblasts’ adipogenic differentiation capacity. 
However, adipogenesis for fibroblasts is an important question still waiting to be 
answered today. 
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2.4 Adipogenesis 
2.4.1 Cellular differentiation 
Differentiation is a mechanism that allows the cells to take more specific tasks in the 
organism. Cellular differentiation continues during the entire life of the organism but 
particularly in development. Several phenotypic changes occur in the cell as a result. 
Metabolic activities of the cell, surface membran proteins, responses to stimuli, cell 
mobility, the shape and size of the cell are some examples of these possible changes. 
An important point here is that the changes occur in phenotype of the cells, not 
genotypes [87]. In general, while all the cells of the organism carry the same 
genome, they can differentiate regarding the regulations of gene expressions. With 
this implication, differentiation can be mentioned as a result of the modifications of 
gene expression. 
The cells with differentiation capacity are called stem cells in the organism. Stem 
cells are classified according to their differentiation capacity or the final cell type 
they differentiate. Zygote which is the first cell of human is a totipotent stem cell. It 
can differentiate into all cell types. Blastocyst cells are pluripotent cells which occur 
in early embryogenesis. These cells also can differentiate into all kind of human cells 
but they can not generate a new organism by themselves. There are 4 main stem cell 
types of an adult human [88]. These are muscle satellite cells, epithelial stem cells, 
hematopoietic stem cells, and mesenchymal stem cells. These cells are multipotent 
stem cells, they can differentiate into particular groups of cell types. This means that 
they have had a limited differentiation, but not complete. This classification system 
ends with unipotency and oligopotency. 
Genes which are associated with the same function in the organism, are called panels 
or subsets. In a specialized cell, a variety of gene subsets are expressed in stead of 
the entire genome [63]. Differentiation is a gene switch on and switch off process. 
Modifications, relations and regulations of genes are primarily involved in 
differentiation biology. 
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Cellular differentiation can be activated by different types of stimuli [90,91]. 
Signalling is the most common stimulation type in humans. Ligands, which trigger 
differentiation, are secreted to the extracellular environments and activate 
differentiation at the cells that carry appropriate receptors. Another important 
stimulation mechanism is direct interactions. These interactions might exist as cell-
to-cell or cell-to-matrix. Today, extracellular matrix proteins are known to influence 
differentiation. There are also epigenetic factors effecting on differentiation [92]. 
2.4.2 Adipogenic Differentiation 
Two main adipogenesis events occur in humans. The first one is the dense BAT 
formation which begins in late pregnancy and the accelerated adipose tissue 
formation in neonatals. This is called early adipogenesis [44]. Today, since there are 
ethical restrictions over the researches made with embryonic stem cells, most of the 
knowledge we have about adipogenesis are belong to adult adipogenesis. 
In adults, multipotent stem cells are first isolated from bone marrow. After that, skin, 
muscle and brain were also used as multipotent stem cell sources [93]. Today, 
adipose tissue also has been accepted as an important source of multipotent stem 
cells [94]. Several studies reported that the multipotent stem cells isolated from 
adipose tissue could even differentiate into cardiomyocyte-like cells [95], insuling-
secreting cells [96] and endothelial-like cells [97]. Late adipogenesis have been 
realized by multipotent stem cells like adipose tissue-derived MSCs. 
Adipogenesis is a complex process that many transcription factors involve. There 
occur many adipose-related gene activations. Adipogenesis is associated with early-
middle-late mRNAs and protein markers [98,99]. However, this distinction is not 
sharp. Genes of different stages are expressed together. Adipogenesis is one of the 
most sophisticated genetic reprogrammings in the organism. Many inhibitory or 
stimulatory transcription factors play important roles (Fig. 2.7). 
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Figure 2.7: Regulatory cascade controlling adipogenesis. Adipocyte differentiation involves the 
interaction between and regulation of transcription factors C/EBPs and PPARγ. 
C/EBPb and C/EBPd are induced early during adipogenesis, in response to hormonal 
stimulation. This is followed by the induction of PPARγ and C/EBPa. There is a 
positive feedback loop between C/EBPa and PPARγ that appears to be important for 
the maintenance of the differentiated state. C/EBPa also appears to play a role in 
controlling insulin sensitivity in adipocytes. ADD1/SREBP1 may enhance PPARγ 
activity through the generation of ligands for this receptor, which forms a heterodimer 
with retinoid X receptor (RXR) [163]. 
In adipogenesis, first of all, the cell is removed from cell cycle and enters into 
differention mood in stead of proliferation mood. This is called growth arrest. This 
change is achieved by the activation of CCAAT-enhancer binding protein (C/EBPβ 
and –δ). Activated C/EBPβ and C/EBPδ directly binds to DNA, and stimulate the 
expression of CDK inhibitor p21 [100]. The accumulation of p21 causes 
hypophosphorylation of retinoblastoma proteins in the cell. Retinoblastoma protein is 
a tumor suppressor protein which is activated by hypophosphorylation. As a 
consequence of these events, the cell stops cell cycle. 
On the other hand, C/EBPβ and C/EBPδ activation leads to an increase in the 
expression of peroxisome proliferator-activated receptor-γ (PPARγ). There are 
different variants of PPARγ in the organism. These variants might have effects on 
adipogenesis [101]. PPARγ increases the expression of C/EBPα in the cell [102]. 
Adipocyte determination and differentiation factor-1/sterol responsive element-
binding protein-1c (ADD1-SREBP-1c) however increases the expression of PPARγ 
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in the cell [103]. Today PPARγ has been considered as a key factor for adipogenesis; 
and C/EBPα has been thought as a factor that contributes to the expression of PPARγ 
to keep it at desired levels [102]. 
Zinc-finger DNA binding proteins GATA-2 and GATA-3 also involve in 
adipogenesis [104]. They serve with their suppressant characteristics. GATA-2 and 
GATA-3 synthesis in progenitor cells holds the cell at pre-adipocyte stage. In a 
research, genetically obese mice have grown from GATA-3 deficient embryonic 
stem cells. Individuals were prone to develop adipose tissues. In another study, 
overexpression of cAMP responsive element binding protein (CREB) in active form 
was sufficient to induce adipogenesis [105]. Accordingly, cAMP can be mentioned 
as a modular that regulates adipogenesis. Many other growth hormones, cytokines 
and factors  are reported which have modulatory effects on adipogenesis. 
Adipogenesis is a gene expression regulation event. Today, PPARγ, perilipin and 
adiponectin are the proteins/markers which are identified with directly adipogenesis. 
These proteins are used to recognize adipocytes. A better understanding of the 
mechanisms and interactions of these proteins will be very descriptive about details 
of adipogenesis. 
2.4.2.1 PPARγ 
Peroxisome proliferator-activated receptors (PPARs) are members of type-2 nuclear 
hormone receptor family. They form heterodimer structure with retinoid X receptors 
(RXR) [106]. 3 subtypes of PPARs are known: PPARα, PPARγ and PPARδ. PPARγ 
among these forms is directly related with adipogenesis [107]. PPARγ gene is found 
on chromosome 3, the location 3p25 [164]. Humans have 3 forms of PPARγ. While 
PPARγ1 is found almost in all tissues except mucle, PPARγ2 is only found in 
adipose tissues. Between these two forms, there is a 30 amino acid difference at their 
N-terminal end, PPARγ2 is longer than PPARγ1. It is believed that these forms of 
PPARs arise as a result of RNA splicing. 
PPARγ is activated before many adipocyte specific proteins. Studies have shown that 
only PPARγ expression is sufficient for growth arrest [108]. As noted before, PPARγ 
takes role with C/EBPα. Transgenic animal studies have shown that PPARγ knock-
out mice have revealed a sharp decrease in the expression of C/EBPα, whereas 
PPARγ expression is very slightly effected in C/EBPα knock-out mice [102]. 
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Furthermore, overexpression of PPARγ tolerates the defect of C/EBPα. These 
findings indicate the supporting role of C/EBPα and the leading role of PPARγ in 
adipogenesis. 
Today, synthetic and natural PPARγ ligands are identified. The drug 
“thiazolidinediones” is one of these ligands. After binding, this drug activates 
PPARγ, and enhances insulin sensitivity of the organism. This action stimulates 
adipose conversion [109]. The most suprising information about thiazolidinediones is 
its strong effect on fibroblasts [110]. 
The effects of saturated and unsaturated fat on cardiovascular health is an issue that 
scientists work on for many years. According to general belief, saturated fatty acid is 
more dangerous for our health. However, a study suggests that unsaturated fatty acid 
might be dangerous as much as saturated one [111]. Unsaturated fatty acid stimulates 
adipogenic differentiation of pre-adipocytes more than saturated fatty acid. It is 
thought that unsaturated fatty acid performs this influence by acting as a PPARγ 
ligand precursor in  the organism. 
Though other PPAR family members are not considered as functionary in 
adipogenesis, their abundant expressions in adipose tissues lead scientists to 
investigate their potentials in adipogenesis [112]. Until now, many proteins have 
been found in interaction with PPARγ [164]. Given duties of these proteins show us 
how important PPARγ is for adipogenesis. 
2.4.2.2 Perilipin 
One of the most characteristic aspects of adipocytes are the significant lipid droplets 
they contain. These subcellular structures are covered with a phospholipid 
monolayer. Lipid droplets do not just serve as triacylglycerol storages, they also play 
role in cellular lipid metabolism [113]. Today, they are considered as organelles 
which exist in many eukaryotic cell types [114]. Lipid droplet biogenesis is not a 
subject well clarified. As well as the formation of golgi apparatus, there might exist 
proteins which interact with surface membrane and give rise to lipid droplets. 
Proteomics studies identified proteins which are involved in lipid droplet biogenesis 
and metabolism. In mammals there are diversified proteins on lipid droplets which 
function in lipid metabolism and membrane traffic. However, great majority of these 
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proteins are PAT (perilipin/ADRP/TIP47 – perilipin super family) protein family 
members [115]. 
Phosphoprotein perilipin is the main member of PAT family, selectively expressed 
only in adipocytes and steroidogenic cells. They are essential for cAMP-dependent 
lipolysis via protein kinase A (PKA) [116]. They prevent the access of lipase 
enzymes to reach to lipid droplets when the cell stands in basal conditions. In 
humans, epinephrine hormone is secreted to blood stream in cases such as increased 
heart rate and decreased insulin secretion. These events cause a higher energy 
demand in organism. β-adrenergic reseptors can be activated by epinephrine and 
their activation leads to phosphorylation of perilipin and hormone sensitive lipases 
(HSL) in the cells and prepare the conditions for lipolysis. Becausen phosphorylated 
perilipins cease holding the lipid droplets and with the new appropriate 
circumstances, HSLs which are activated by phosphorylation anchor to lipid droplets 
[117]. 
Perilipin genes are dispersed in human genome [161]. Today, 5 different perilipin 
subtype is defined in humans. These subtypes can be mentioned either with numbers 
or letters. Perilipin 3 (perilipin C) gene is located on chromosome 19. Perilipin 3 
proteins interact with mannose 6-phosphate receptors (MPRs) and assist to the 
transfer of lysosomal hydrolase enzymes from golgi apparatus to endosomes. 
Perilipin 4 and perilipin 5 are generally considered as lipid droplet coating proteins. 
They are expressed from perilipin 3 gene and taken their latest status with splicing. 
These proteins are not adipocyte specific markers. 
Perilipin 2 (perilipin B) gene is located on chromosome 9. Although the protein 
serves in lipid droplet metabolism, it is not considered as an adipogenic marker since 
it is expressed in different types of cells. Cell cultivation studies revealed that 
perilipin 2 proteins are encountered in Sertoli cells, epithelial and endothelial cells . 
Perilipin 1 (perilipin A) is an adipogenic marker for humans, it is just synthesized in 
adipocytes. The gene is found on chromosome 15, the location 15q26. It is a basic 
substrate of cAMP-dependent protein kinase. Therefore, after a signalling series 
which activate this kinase, it gets phosphorylated by the enzyme [116]. This event 
allows the access of lipases to lipid droplets and starts lipolysis. 
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Gouri Ranganathan and colleagues reported expression of perilipin might trigger and 
increase obesity [118]. On the other hand, this might also be mentioned as increased 
gene expression of perilipin is found in cases of obesity. However, Ranganathan 
could not find a direct relation between perilipin expression and insulin resistance. 
The question is, does which one trigger the formation of the other one? As a result, 
perilipin, as a causing factor of obesity, is an issue waiting to be understood. 
There is an interesting subject needs to be told at this stage. Mesenchymal stem cells 
(regardless they are derived from bone marrow or adipose tissue) and fibroblasts are 
spindle shaped cells. Adipogenesis makes the cells sephirecal shaped. In addition, 
with increasing adipogeny, lipid droplets occur in the cells that can be seen under 
microscope. These are phenotypic factors that allow the selection of adipocytes. 
However, as is understood from given statements, perilipin 2 expression and lipid 
droplet formation can occur in the cells which are not adipocytes. This prevents the 
use of lipid droplets as adipogenic markers. Microscope images of oil particles need 
to be verified with gene expression analyses. Nevertheless, perilipin 1 expression is 
an important adipogenic marker. 
2.4.2.3 Adiponectin 
Adiponectin (Acrp30, apM1, GBP28, AdipoQ) is the most commonly synthesized 
protein in adipos tissues. In a given time, adiponectin composes 0,01% of the total 
proteins in human’s circulatory system. This concentration is even 1000 times bigger 
than the most frequently produced hormone [119]. Adiponectin is only synthesized 
in adipose tissue (Fig. 2.8). Because of the explained features, adiponectin was first 
called adipose most abundant gene transcript (apM1). 
 
Figure 2.8: Adiponectin expression profile in human. By using northern blotting, 
different human tissues were investigated to find adiponectin mRNA. It 
is just observed at adipose tissue (modified [165]). 
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Adiponectin is secreted into blood stream by WATs. In obesity and type-2 diabetes, 
plasma adiponectin leves are reduced and insulin resistance increases [119]. It takes 
active roles in glucose metabolism and fatty acid catabolism [38]. It stimulates NO 
synthesis from endothelial cells [120]. In type-1 diabetes, high plasma adiponectin 
levels are encountered and this indicates that adiponectin supports glucose intake 
[121]. Adiponectin blocks protein kinase-A (PKA) activity by effecting on platelet-
derived growth factor subunit B (PDGFB) in smooth muscle cells. As a result, cell 
proliferation and migration stop [122]. What is more, adiponectin has important 
immunomodulatory functions in the organism [120]. In various cancer types, serum 
adiponectin levels remain lower than normal [123]. Lipid metabolism is just one the 
functions of adiponectin and these data offer that adiponectin takes on many other 
important duties in humans. 
Adiponectin is a product of apM1 gene. This gene is found on chromosome 3, the 
location 3q27 [162]. It has 3 exons and 2 introns. Expression of adiponectin is under 
control of various intracellular and extracellular factors such as C/EBPβ, PPARγ, 
Nuclear factor-Y (NF-Y), insulin activity and β-adrenergic stimulation. Its synthesis 
is higher in SATs [124]. It includes 4 different subunits. These are the signal 
sequence at N-terminal part, the variable domain beside, a collagen-like domain and 
lastly, a globular domain. Within this structure, adiponectin resembles to tumor 
necrosis factor – alpha (TNF-α) and complement factor C1q [125]. Adiponectin 
molecules are attached together and structure a polymer form in circulation. 
However, adiponectin polymer forms differ between women and men. 
Although there are myriad of receptors affected by adiponectin in the organism, just 
2 adiponectin receptors were cloned [126,127]. These are ADIPOR1 and ADIPOR2 
proteins. Activation of these molecules induces PPARα and AMP-activated protein 
kinase (AMPK) activation in the cell. AMPK is an important cellular enzyme for 
energy homeostasis which is actively produced in several tissues. It inhibits 
cholesterol synthesis whereas stimulates fatty acid oxidation and lipogenesis. 
Furthermore, AMPK serves as a regulatory factor in insulin secretion. Suprisingly, It 
can either inhibit lipolysis and lipogenesis in adipocytes [128]. This means 
adiponectin can prevent adipose tissue expansion in organism. Therefore, it is 
believed that only terminally differentiated adipocytes synthesize adiponectin. 
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2.4.3 PPARγ, perilipin and AdipoQ – early or late markers? 
Though these proteins have very different functions and features, the common 
character they share is their belonging to adipose tissue. PPARγ is very active at 
initiation and maintenance of adipogenesis. Perilipin is very important for structural 
transformation of the cell. By supporting lipid droplet constitution in the cell, they 
provide important contributions to adipogenic phenotypes. Adiponectin is even 
explanatory in itself about how important adipose tissues are for humans. It is one of 
the most important tools for adipocytes to perform their tasks in organism. 
Accordingly, PPARγ is a protein which is involved in both early and late stages of 
adipogenesis. They are associated with differentiation of adipocytes rather than their 
adipogenic duties in the organism. Thus, PPARγ expression in the cell is expected to 
be in stable levels. Perilipin expression starts right after settling the appropriate 
conditions in the cell which allow the cell to produce lipid droplets. Depending on 
the lipid metabolism in the cell, perilipin expression would increase or decrease. 
Adiponectin is an instrumental protein for adipocytes to carry out their duties. 
Therefore, only completely differentiated adipocytes are expected to synthesize 
adiponectin molecules and this leads adiponectins to be known as late markers. 
2.5 Extracellular Matrix 
2.5.1 What is extracellular matrix? 
Extracellular matrix (ECM) layer is one of the most important features of connective 
tissues [129]. It is classified under two types. The first one is interstitial matrix. This 
matrix can be considered as a lute material between cells. It is formed by 
proteoglycans, non-proteoglycan polysaccharides and fibrous proteins which are the 
molecules that cells secrete to extracellular environments or diretly locate onto their 
surfaces. These molecules fill the interstitial space. Second group of ECM is known 
as basement membrane [130]. It is the large fibrillar structure lying beneath 
epidermis layer. 
ECM structure differs according to its location in the organism. The organs, tissues 
and cells that ECM is in contact are determining about this issue. Basement 
membrane occurs between epidermis and dermis layers. In addition, outer surfaces of 
many organs and blood vessels are surrounded by basement membrane. It is an 
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advanced pool of mostly fibrillar proteins. The merger of basal lamina that is formed 
by epidermis cells and reticular lamina which is formed by reticular cells, composes 
basement membrane structure. Reticular cells are special fibroblasts. Adipose tissues 
are held together by reticular fibers and so basement membrane [131]. The most 
abundant proteins in basement membrane are collagen fibrils and laminin proteins 
[129]. 
Interstitial matrix serves as the filling material in connective tissues. Skin 
hypodermis layer is very abounding in interstitial matrix. It is especially produced by 
fibroblasts. It seperated the tissues. Moreover, it controls intercellular 
communication in these tissues. It is vital for processes such as growth, fibrosis, 
wound healing [132]. As conclusion, interstitial matrix can be thought as a 
workspace for cells. 
ECM layer is crucial for growth; it enables signalling traffics of cells. Today, the 
unique importance of ECM for development is started to be understood. This is 
related with the included molecules about how they affect other cells. For example, 
adipocytes and progenitor cells are surrounded by a thick ECM layer in adipose 
tissues. The discovery of paracrine and endocrine features of adipocytes proves us 
how important this layer for the continuity of the organism. Because adipocytes need 
ECM to realize their duties. But on the other hand, are there effects of ECM on 
progenitor cells? This is the question of whether ECM regulates or disturbs 
differentiation in the organism. Above all, differentiation is a very complicated 
process which can be effected by many factors, and it would be normal if behaviors 
of progenitor cells are effected, since ECM is a layer which they are in continuous 
contact. Today it is a matter of interest if the protein content of ECM influences 
adipogenic differentiation in humans. 
2.5.2 Proteins of Extracellular Matrix 
ECM proteins are secreted by exocytosis from the cells [133]. In addition, 
extracellular surface proteins might also involve in ECM. Fibrillar collagens are the 
main proteins of this layer [132]. Also, fibrillar elastins are found in big amounts in 
ECM, they give the elastic nature to ECM. By the attribute of elastins, ECM can 
return to its original state after being bended [134]. The most important non-fibrillar 
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proteins are fibronectins in ECM. Besides, laminins are also another important non-
fibrillar proteins in this layer. 
2.5.2.1 Collagens 
Collagen is an animal protein which is especially found in connective tissues of 
mammals. It is the most abundant protein and very vital for the survival of organisms 
[135]. From contractions of muscles to seeing process, collagens are involved in 
many cases. 
Collagens is a protein family which share a similar trimeric structure and functional 
properties [136]. There are 5 subgroups of collagens. These are fibrillar collagens 
(type I, II, III, V, VI collagen), short chain collagens (type VIII, X collagen), 
basement membrane collagens (type IV collagen), fibril-associated collagens with 
interrupted triple helices (FACITs) (type IX, XII, XIV, XVI, XIX collagen) and 
membrane-associated collagens with interrupted triple helices (MACITs) (type XIII, 
XVII collagen). All collagen subtypes contain triple helical domains, which are in 
left-handed helix forms. These domain formations are generally structured by Gly-
Pro-X or Gly-X-Hyp repeat amino acid sequences. Glycine is known as the smallest 
amino acid which does not have a side group. Therefore, it is seen in every third 
position in collagen helices. This triple structures create the appropriate conditions 
for hydrogen bonds and provide the stability of collagen fibrils. 
The most abundant form of collagens is type-I collagens. It is the main component of 
organic parts of bones [137]. Moreover, collagen type-I constitutes endomysium 
structures in muscles and therefore, it is very important for healthy functions of them. 
This protein is also in abundant in tendons [138]. They are mainly synthesized by 
fibroblasts. In wound healing cases, there occurs an excessive increase in collagen 
production. The abundant occurence of collagen type-I proteins in organic parts of 
bones brings the idea if they can effect on cellular differentiation of mesenchymal 
stem cells. 
Collagen type-IV is located in basement membrane [139]. Glycine amino acids 
which are required in every third position for a tight structure do not exist in collagen 
type-IV subunits. This causes a sheet-like structure for these proteins in stead of a 
helical structure. Thus, formation of basal lamina occurs.  
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The effects of collagens (collagen type-I) have been identified over osteogenesis 
[21]. Considering the important role of basement membrane in maintaining the 
adipose tissue formation, the possible effects of collagen type-IV on adipogenic 
differentiation would not be a suprise. 
2.5.2.2 Fibronectins 
Fibronectins are found in glyprotein form in ECM; they are big molecules with an 
average weight of 450kDa. Fibronectins can bind collagens and at the same time, 
they can bind cellular surface proteins, integrins and allow the cell movement. 
Fibronectin proteins have relatively complicated structures. They are found in 
dimeric formations [140]. The dimeric subunits are formed in 3 modules and these 
modules are formed in 2 β-sheet peptides. These modules determine the functions of 
fibronectins. Different forms of fibronectines can be produced by alternative 
splicing. Two main types of fibronectins are synthesized in humans which are 
soluble and insoluble. Insoluble form is one of the basic components of ECM and 
they are mainly synthesized by fibroblasts. 
Fibronectins are involved in the formation of thrombus (blood clot) in wound areas 
[141]. Construction of thrombus is the last step of blood coagulation. The seperation 
of soluble and insoluble fibronectins are very indicative in this process. Soluble 
fibronectins give rise to thrombus structure. However, in wound healing stage, 
fibroblasts start to excrete protease enzymes to the area for recovery. This application 
causes the general digestion of the proteins in that area. After that, exchange of 
plasma fibronectins with cellular fibronectins which are insoluble are done by 
fibroblasts. This mechanism is essential for wound healing and furthermore, ECM 
assembly. 
The effects of fibronectins in cell movement lead the scientists to investigate their 
possible roles over invasions of cancer cells. However, before invasion, their roles in 
carcinogenesis were discovered [142]. Jesse Roman and colleagues found the 
stimulation of gonadal steroids by fibronectins in their research. Gonadal steroids 
interact with vertebrate androgen receptors and control the expression of cyclin D in 
the cells. Therefore, fibronectins can indirectly change the cell cycle status of the 
cell. In another study with fibronectin knock-out transgenic mice, lack of 
embryogenesis has been showed [143]. Deprivation of fibronectin leads to the 
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defects in mesodermal and vascular development. It is a matter of wonder if 
fibronectins with such important roles on growth might have effects on cellular 
differentiation. 
2.5.2.3 Laminins 
Laminin proteins are located in basement membrane in trimeric structures. 
Occurence of α, β and γ chains allows the diversity of laminins [144]. They creates 
spider web-like networks in stead of fibrillar forms. They can interact with ECM 
molecules or cell surface proteins. Collagen type-IV is one of these molecules. 
Laminins play roles in cell attachment [145]. They are very important in terms of cell 
shape and cell motility. Moreover, laminins are the only proteins which their relation 
with cellular differentiation has been demonstrated among the mentioned ECM 
proteins in this work. They are commonly used in cell cultures [146]. It is possible to 
make pluripotent cell cultures with the usage of laminins. Laminins are important 
tools for understandings of cellular interactions with extracellular matrix. The uses of 
laminins in cell culture essays led to the studies which investigate the effects of 
laminins on differentiation. However, the findings over this issue are observational 
discoveries, intracellular effects are not well known yet today. However, in some 
neural development experiments, few clues were found about their intracellular 
activities. Accordingly, it is thought that laminins cause changes in the level of 
intracellular cAMP amounts [147]. 
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3. MATERIALS AND METHODS 
In this research, the main subject was understanding the adipogenic differentiation 
potentials of mesenchymal stem cells (MSCs) and dermal fibroblasts. According to 
this intention, the cell lines were cultured in adipogenic differentiation and control 
mediums. In addition, cultivation of MSCs in coated vessels with extracellular matrix 
(ECM) proteins were done. Lastly, two main detection techniques were performed: 
- Quantitative real time polymerase chain reaction (qRT-PCR) 
- Immunofluorescence Staining 
3.1 Materials and equipment 
3.1.1 Equipment 
The laboratory equipment used during this study is listed in Appendix A 
3.1.2 Compounds, kits and buffers 
The compounds and commercial kits used during the study are listed in Appendix B; 
the recipes of buffers  and media used in the experiments are given in Appendix C. 
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3.2 Methods 
3.2.1 Cell culture and differentiation 
3.2.1.1 Isolation of MSCs  
Two mesenchymal stem cell strains derived from bone marrow (BM72 & BM78), 
one from adipose tissue (LA47) and one human forehead dermal fibroblast culture 
(DF24) were provided by Karen Bieback and colleagues from Institute of 
Transfusion Medicine and Immunology, Medical Faculty Mannheim, University of 
Heidelberg. In short explanation, concerning the ethical issues [73], bone marrow 
aspirates and lipoaspirates were treated with a series of digestion, dilution and 
centrifugation steps in order to assort the cells. Afterthat, for the suspension of 
MSCs, cell isolates were seeded in MSC-Growth Medium (Lonza, Cologne, 
Germany) at a density of 1 x 106 cells/cm2 into T75 or T175 culture flasks (Nunc, 
Rochester, NY, USA; Greiner, Frickenhausen, Germany). After the first medium 
change, non-adherent cells were removed and fibroblastoid cells kept proliferating in 
culture. 
3.2.1.2 Preparation of ECM coated culture vessels  
In order to perform adipogenic differentiation on ECM-proteins, culture flasks were 
coated by collagen type-I (rat tail tendon; Roche), collagen type-IV (human placenta; 
Sigma-Aldrich), fibronectin (human plasma; Roche) and laminin (mouse EHS-
tumor; Roche) proteins. 
Laminin was supplied 0,5 mg/ml in 0,15 M NaCl, 2 mM EDTA and 0,05 M Tris HCl 
solution (pH 7,4). Flask surface was incubated with 5 µg/cm2 laminin for 1h at 370C. 
Solution was aspirated from the vessels and cell were added. 
Fibronectin was diluted with 5 ml sterile water for 1 mg/ml last concentration. 
Afterwards, flask was coated with 5 µg/cm2 solution for 1h in incubator at 370C. 
Then solution is removed very gently and vessels is washed for one time with 
medium and cells were added. Collagen type-I was dissolved in 0,2% acetic acid for 
the last concentration 2 mg/ml. Coating was performed with 5 µg/cm2 solution in 
incubator at 370C for 1h. 
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Then collagen solution was aspirated and surface was washed with PBS for 2 times. 
Afterwards, cells were added. Collagen type-IV coating was made with the same 
conditions with collagen type-I coating. However, dissolving collagen type-IV is a 
harder process, thus, dissolvement in the solution took several hours. 
3.2.1.3 Cell culture and proliferation 
MSCs were proliferated in MSC-GM whereas fibroblasts were cultured with 1x 
DMEM medium containing 10% FCS and 1% penicillin/streptomycin. Incubations 
were performed in humidified atmosphere at 370C, 5% CO2, 95% air in T175 culture 
flasks (Greiner Bio One, North Carolina, USA). 
Cells were split until we had enough number of cells for the experiments. For this 
purpose, 1 x trypsin-EDTA (PAA) solution was used for passaging the cells. The 
cultures which reached 70-80% subconfluency were treated with 1 x trypsin-EDTA 
solution for one minute and moved to fresh media. The media include inactivating 
agents for the enzyme, thus trypsin in the solution gets inactivated. This is very 
important because, trypsin is a protease which cleaves peptid residues [148]. In 
biotechnology, we use this enzyme to re-suspend the cells from vessel surface. 
However, treatment the cells more than one minute causes the cleavage of the cell 
surface proteins by trypsin and this is harmful for the cells. 
3.2.1.4 Cell Counting 
Regarding the standardization concerns, the number of the cells which are used for 
the cultivation of differentiation is an important issue. Cultures need to be initiated 
with the same number of cells, therefore population density will effect the behavior 
of the cells in the same manner. According to this, the cells were seeded after 
counting. 
The number of the cells which were used for seeding was counted using an automatic 
cell counting system (Fig. 3.1, Vi-Cell XR Cell Viability Analyzer, Beckman 
Coulter, Miami, USA). This system uses conventional trypan blue dye exclusion 
method. However, the well automated system takes 50 photographes of each cell 
suspension and gives the average number of the cells. It indicates the viability ratios 
of the cells indeed. Accordingly, 1000 µl cell suspensions were counted with dilution 
factor 2.0. 
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Figure 3.1: Vi-Cell XR Cell Viability Analyzer, Beckman Coulter, Miami, USA 
(www.beckmancoulter.com). 
3.2.1.5 In vitro differentiation of MSCs and fibroblasts 
MSCs and fibroblasts were seeded to the flasks for differentiation experiments. The 
initiation number of MSCs were 2 x 104 cells/cm2 whereas fibroblasts were 1,5 x 103 
cells/cm2 in T25 culture flasks (Greiner Bio One, North Carolina, USA). On the 
other hand, fibroblasts were seeded onto glass coverslips (SPI supplies, West 
Chester, USA) with 0,9 x 105 cells/ml (3ml in total) for immunofluorescence staining 
purpose. 
All the cells were kept in growth media until they reached to confluency. The 
necessity of growth arrest for differentiation has been mentioned before [63]. The 
cells can not differentiate if they keep proliferating. Therefore, it is a must to wait 
untill confluency in cell culture. When the cells reach to confluency, they are ready 
to start differentiation. 
After observation of 80% population concentration in the flasks, adipogenic 
differentiation was initiated by adipogenic induction medium (AIM, Lonza). This 
medium contains adipogenesis stimulation factors such as dexamethasone, 
indomethacin, recombinant human insulin and 3-isobutyl-1-methylxanthine (IBMX). 
3 days later, AIM was removed and cells were treated with adipogenic maintenance 
medium (AMM, Lonza) for two days. This medium lacks the differentation factors 
IBMX, dexamethasone and indomethacin. This set of treatments were done for three 
times during 14 days. The daily schedule of differentiation essays is listed in Table 
3.1 via fibroblasts. 
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During the experiment, unstimulated control groups were kept in growth media. 
Table 3.1: Adipogenic differentiation plan of fibroblasts. 
d0 d1 d2 d3 d4 d5 d6 d7 d8 d9 d10 d11 d12 d13 d14 
 A.D. AIM AIM AIM AMM AMM AIM AIM AIM AMM AMM AIM AIM AIM AMM AMM 
FibAD1 > > X*                         
FibAD2 > > > > > X                   
FibAD3 > > > > > > > X               
FibAD4 > > > > > > > > > > > > > > X 
FibAD5 > > > > > > > > > > > > > > > 
Control d0 d1 d2 d3 d4 d5 d6 d7 d8 d9 d10 d11 d12 d13 d14 
  GM GM GM GM GM GM GM GM GM GM GM GM GM GM GM 
FibC1 > > X                         
FibC2 > > > > > X                   
FibC3 > > > > > > > X               
FibC4 > > > > > > > > > > > > > > X 
FibC5 > > > > > > > > > > > > > > > 
*X refers to sampling days. A set of 3 days AIM and 2 days AMM treatments were 
performed for three times 
3.2.2 RNA isolation and reverse transcription reaction 
3.2.2.1 RNA isolation 
RNA isolation is the first and one of the most important steps of a successful gene 
expression analysis. Since RNA is a very diversified and sensitive molecule, it needs 
to be handled very carefully. 
In this study, after trying a few RNA isolation kits, we decided to use Qiagen 
RNeasy Kit (Qiagen, California, USA) regarding to its performance. At sampling 
times, cells were washed with 5 ml PBS (PAA) for two times and lysed in 600 µl 
RLT buffer (Qiagen) including 0,6 µl β-mercaptoethanol (Applichem). This is a 
special solution of the kit to loosen the cells from surface. During the exposure with 
RLT buffer, surface is disturbed with a sterile spatula for an efficient gathering of the 
cells. This cell suspension is filtered in Qiashredder spin-columns (Qiagen) to 
homogenize the cell lysates. Afterwards, the filtered solution is treated with a set of 
buffers in RNeasy mini spin columns (Qiagen) to seperate and reserve the total RNA 
content of the cells. Eventually, RNAs are solved in 40 µl RNase-free water 
(Qiagen). 
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3.2.2.2 Quantification of the isolated RNAs 
RNA is a very unstable molecule. It is open to the negative effects of RNase 
enzymes which is located almost everywhere and it is very easy to lose RNA 
molecules during the processes. Thus, we need to be sure about the healthy existence 
of RNAs in our tubes. On the other hand, for a standart reverse transcription reaction, 
same amount of sample RNAs need to be used. Therefore, a healthy measurement of 
these RNAs is a vital process for the fate of the study. 
According to the concerns, sterile working issues had been followed especially by 
using RNase disinfectant solution (RNase-ExitusPlus, Applichem, Denmark) on the 
working areas. RNAs are measured with Nanodrop ND 1000 V 3.3 (Thermo 
Scientific, Wilmington, USA) spectrophotometer. 
3.2.2.3 Reverse transcription (rt) reaction 
After some trials of different reverse transcription reaction kits, Transcriptor High 
Fidelity cDNA Synthesis Kit (Roche Diagnostics, Mannheim, Germany) was chosen. 
1 µg RNA was determined as the standart amount of RNA for every reaction. 1 µg 
RNA was reverse transcribed using 1 µl anchored-oligo(dT)18 primer (2,5 µM). 
The cDNA was snythesized from total RNA using the high fidelity kit in two steps. 
In first step, reaction is performed to open RNA molecules and create efficient 
conditions for the proper annealing of the primers. In second step, reverse 
transcription of the RNA into cDNA is performed by the enzyme. 
In a 20 µl standart reaction tube, there are 4 µl of buffer (5 x concentration), 0,5 µl of 
RNase inhibitor (40 U/µl), 2 µl of dNTP (10 mM each), 1 µl of DTT (5 mM), 1,1 µl 
of transcriptase enzyme (10U/l), 1000 ng RNA and enough PCR degree water. 
Overview of the reaction is presented in Figure 3.2. Reaction conditions are 
mentioned in Table 3.2. 
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Table 3.2: Conditions of rt reaction for quantitative PCR. 
 
           10 Min’ at 650C Incubation                30 Min’ at 550C & 5 Min’ at 850C 
 
 
Figure 3.2: Main steps of the rt reaction (from Transcriptor High Fidelity cDNA 
Synthesis Kit manuel). 
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3.2.3 Quantitative real time polymerase chain reaction (qRT-PCR) 
3.2.3.1 A brief overview of qRT-PCR 
The basic polymerase chain reaction (PCR) is a molecular biology technique which 
allows scientists to amplify the demanded DNA sequence in vitro [149]. 
Accordingly, a special thermostable polymerase enzyme catalyzes the amplification 
reaction with the guidance of specific primers (Fig. 3.3). Template DNA and four 
main type of deoxynucleoside triphosphates (dNTP) are needed for the newly 
synthesized millions of strands. There are also additional compounds to support the 
reaction such as buffers, ions and performance-enhancing molecules. 
With time, very different and 
advanced types of PCR techniques 
have been developed [150]. Some 
progressions even let the scientists 
to analyze their target sequences via 
RNA molecules. For this purpose, 
with a special enzyme, RNA 
template is converted into DNA 
molecules and it is called 
complementary DNA (cDNA). This 
started to be achievable after the 
discovery of in vitro usage of 
reverse transcriptase enzyme [151]. 
 
 
 
 
 
cDNA synthesis from RNA molecules is called reverse transcription reaction. This is 
a milestone finding for molecular biology because following the gene expressions 
inside the cell on real-time is done today by rt reaction. 
Figure 3.3: PCR starts with the denaturation of double strand DNA. After 
denaturation, primers anneal to their complementary sequences on 
single strands. Synthesis of the new strands is catalyzed by special 
polymerases. In every reaction turn, two daughter double-stranded 
DNA is produced from  the parent strand. 
www.oceanexplorer.noaa.gov 
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Real-time polymerase chain reaction is a kind of PCR with an additional feature that 
includes continous collection of fluorescence signals from every reaction turn. So, 
RT-PCR contains special probes and fluorophore systems in addition. The analyze of 
the fluorescence signals in every each turn and their convertions into numerical 
values by a developed software make the reaction quantitative [152]. Today, there 
are several types of different probe & signalling systems in use. For instance some 
hybridization probes, which bind to the target sequences, start to give fluorescence 
signals after hydrolysis during the PCR. On the other hand, there are special 
fluorescence dyes which only bind DNA double-strand non-specificially. This 
means, the more synthesis of double-stranded DNA in reaction tube, the more 
stronger fluorescence signals the system detects [152]. LightCycler 480 Real-Time 
PCR and Universal ProbeLibrary systems are used for quantitative gene expression 
analyses in this study (Roche Diagnostics, Mannheim, Germany). 
3.2.3.2 Locked Nucleic Acid (LNA) based probes 
The term, probe, refers to an oligonucleotide sequence in molecular biology. The 
most common types of qRT-PCR is done with a probe system which contains a 
signal molecule on the 3’ end and a dark quencher dye on the 5’ end of the molecule. 
The quencher molecule absorbs excitation energy (the signal in this case) from the 
fluorophore molecule as long as the probe stands as a whole. However, the probe 
binds to its complementary sequence which is located in somewhere but on the way 
of DNA polymerase enzyme. As a matter of fact, probe is removed and fragmented 
by the enzyme regarding its 3’-5’ exonuclease activity. Disintegration of the probe 
causes the seperation of fluorophore and quencher molecule, and therefore it gets 
possible to collect the signals from reaction tube (Fig. 3.4). The signal strength 
shows a logarithmic increase after every qRT-PCR turn if the reaction goes well. 
 
Figure 3.4: White circle 
refers to the fluorophore 
molecule whereas black 
circle refers to the dark 
quencher dye. After the 
disintegration and 
fragmentation of the 
probe by the enzyme 
DNA polymerase, it gets 
possible to collect  the 
signals from reaction 
tubes [150]. 
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Universal ProbeLibrary system (UPL) consists of 165 short hydrolysis probes which 
are designed with the mentioned probe structure [153]. There is fluorescein molecule 
(FAM) on the 3’ end of UPL probes. FAM is the most common type of fluorophore 
molecules in use in qRT-PCR. UPL probes perform an extensive transcript coverage 
regarding their prevalent and 8-9 nucleotides short sequences. Moreover, they are 
designed complementary to the exon-exon junction spanning sequences to eliminate 
the difficulties caused by sequential obstacles. Determination of the UPL probes are 
set by ProbeFinder Assay Design Software (Roche Diagnostics, Mannheim, 
Germany). The matter which makes these probes special is the incorporation of 
locked nucleic acids (LNA) into the sequences. 
LNA is a bicyclic RNA analog where the ribose sugar is structurally constrained by a 
methylene bridge between the 2’-oxygen and the 4’carbon atoms (Fig. 3.5). 
Molecular form of LNA makes it more thermostable, therefore the LNA content 
raises the denaturation temperature of the probe [154]. This feature increases 
accuracy rates [155]. Because DNA polymerase catalyzes the reaction at 59-610C 
temperature which is a high degree for the sequential mismatches in reaction. 
 
Figure 3.5: Molecular structures of DNA, LNA, and RNA [156]. 
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3.2.3.3 qRT-PCR conditions and primers 
qRT-PCR is performed with LightCycler 480 Real-Time PCR instrument (Roche 
Diagnostics, Mannheim, Germany). Reaction conditions are listed in Table 3.3. 
Table 3.3: Conditions of qRT-PCR. 
 [0C] Time Ramp rate [0C/s] Cycles 
Denaturation 95 10 min 4,8 1 
Amplification 95 10 sec 4,8 45 
60 30 sec 2,2 
72 1 sec 4,4 
Cooling 40 10 sec 1,5 1 
Besides the three marker genes, five housekeeping genes were tested and three of 
them were determined as the most stable expressed genes [157]. This step was 
necessary to calculate the normalization factor which gives us the general gene 
expression profile of the cells. The final gene expression results of marker genes 
were found by relative comparisons with the three housekeeping genes’ expressions. 
These genes are β2 microglobulin (B2M), glycerinaldehyd-3-phosphate 
dehydrogenase (GAPDH) and TATA box binding protein (TBP). Primer sequences 
and UPL probe numbers of the complete set of genes are given in Table 3.4. 
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Table 3.4: Genes, primer sequences and UPL probes. 
Genes Primer Sequences [5’-3’] UPL 
probes* 
Amplicon 
length 
Tm0 GC 
% 
B2M s_ttctggcctggaggctatc 42 86 nt 64,3 57,8 
as_tcaggaaatttgactttccattc 62,9 34,7 
GAPDH s_tccactggcgtcttcacc 45 78 nt 65,3 61,1 
as_ggcagagatgatgaccctttt 64,2 47,6 
TBP s_cccatgactcccatgacc 51 108 nt 64,1 61,1 
as_tttacaaccaagattcactgtgg 62,6 39,1 
PPARγ s_caggaaagacaacagacaaatca 7 94 nt 63,0 39,1 
as_ggggtgatgtgtttgaacttg 64,1 47,6 
perilipin s_ggacacagtggtgcattacg 64 70 nt 64,1 55 
as_gtcccggaattcgctctc 64,8 61,1 
ADPQ s_ggtgagaagggtgagaaagga 85 61 nt 64,4 52,3 
as_tttcaccgatgtctcccttag 62,9 47,6 
* ProbeFinder Assay Design Software (Roche Diagnostics, Mannheim, Germany) 
Primer efficiencies and normalization factors were also other important tools which 
are considered during the determination of the primers [157]. Gene expression 
analyses were duplicated for every gene in each sample in order to gain more reliable 
data and the average Ct values of duplicates were used in calculation. A cDNA mix 
of three adipocyte samples were used as positive control. The general layout of the 
qRT-PCR plates is shown in Table 3.5. The application of master mix is listed in 
Table 3.6. 
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Table3.5: Plate layout of qRT-PCR. 
Plate  TBP TBP B2M B2M GAPDH GAPDH PPARγ PPARγ Perl. Perl. ADPQ ADPQ 
S*  1 2 3 4 5 6 7 8 9 10 11 12 
S A x x x x x x x x x x x x 
S B x x x x x x x x x x x x 
S C x x x x x x x x x x x x 
S D x x x x x x x x x x x x 
S E x x x x x x x x x x x x 
S F x x x x x x x x x x x x 
(-)* G x x x x x x x x x x x x 
(+)* H x x x x x x x x x x x x 
*S: Samples, (+): Positive control, (-): Negative control 
Table 3.6: The content of reaction in every well. 
 
As emphasized before, detection of the fluorescence signal accumulation is important 
for a successful qRT-PCR. However, this is not an easy process even for well 
developed detection systems of the instrument. Therefore, signals can be detectable 
after exceeding background level of fluorescence and this happens after a number of 
reaction cycles. Cycle threshold (Ct) value refers to the total number of cycles which 
signals start to be detectable. This means Ct values are considered inversely with the 
amount of target gene expression. 
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In other words, if there is a high frequently expressed gene, the number of cycles will 
be lower to catch the threshold cycle. So, the lower Ct value, the higher amount of 
nucleic acid. 
29 and lower Ct values mean an abundant occurence of gene expression product. 30 
– 37 mean positive reactions with a moderate expression of the gene. 39 – 40 Ct 
values exhibit no expression. An example of Ct value graphic is presented as Figure 
3.6. This example belongs to a MSC sample’s perilipin expression which was at day 
14 of adipogenic differentiation. 
 
Figure 3.6: Perilipin expression of a BM-MSC sample at day 14 of adipogenic 
differentiation. The reaction is done for two times with the same 
sample. Ct value of the first curve is 24,60; Ct value of the second curve 
is 24,58. Signal amplification can be seen. 
3.2.3.4 Calculation from Ct values 
Normalization process 
To date, gene-expression analysis has changed the progress of many researches in 
molecular biology. It allows scientists to look inside of complicated regulatory 
networks, signalling pathways, implication of diseases and relate the genes with 
biological processes. 
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Though there are several ways, two recently developed techniques get ahead of gene 
expression analysis. These are microarrays and qRT-PCR. 
These techniques reveal different advantages. qRT-PCR provides the measurement 
of gene expression simultaneously [152]. This feature can be made for many 
different samples but for a limited number of genes. Its high throughput, speed and 
automation levels make it much more advantageous comparing with conventional 
techniques. However, no matter how advanced technology is used, this approach 
needs the normalization of mRNA quantification [157]. 
Efficiencies of enzymes and primers, amounts of starting material, differences of 
cells and their metabolic activities are the several variable factors which need to be 
controlled for an informative gene expression analysis. Standardization of these 
variations is called normalization. This process is actually starts from the begining of 
the experiments. For instance, using same amount of RNA of each sample for rt 
reaction is a tool of normalization. Even though there is a hard debate if RNA mass 
quantity can be mentioned in that way, it is not hard to predict that using 3 ng/µl and 
50 ng/ µl might effect the general results. 
Today, internal control genes are most frequently used factors to normalize the 
mRNA fraction. Although housekeeping gene expression can exhibit differences 
considerably, they are the best candidates which are in use to calculate the 
normalization factors [159]. Jo Vandecompele and colleagues chose 10 commonly 
used house-keeping genes to evaluate their skills for normalization [157]. 
Accordingly they used 13 different types of human tissues. At the end of their study, 
they ranked the control genes in order of their expression stability. The genes and the 
primers, β2 microglobulin (B2M), glycerinaldehyd-3-phosphate dehydrogenase 
(GAPDH) and TATA box binding protein (TBP) were chosen regarding these 
findings. 
Calculation of normalization factors 
Since there is no such unit that can refer the gene expression stages, the general 
metabolic activity needs to be calculated to talk about standart gene expressions. This 
calculation gives us normalization factor. Relative quantification is realized through 
normalization factor. 
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The geNorm algorithm (VBA applet for MS Office Excel) validates the gene 
expression normalization factor based on the geometric mean of reference genes. The 
mathematical equations and formulas are mentioned in Jo Vandecompele’s study 
[157]. The geNorm software is the application of the set of these formulas for regular 
usage. 
Table 3.7: Primer efficiency values. 
 
 
 
Real time primer efficiencies are as important as Ct values for a healthy calculation 
of normalization factor. Primer effeciency values are calculated with a serie of qRT-
PCR trials which are made with the primer of interest and housekeeping genes. Mean 
and standart error of the mean of reactions give us primer efficiencies. The values for 
primers are listed in Table 3.7. Average of positive controls of every plate is also 
another important tool of normalization factor calculation. To conclude, 
normalization factor is found with calculating Ct values of control housekeeping 
genes’ expressions with geNorm algorithm. Consideration of general metabolic 
activity of the cell, abundance of the genes and other flexibilities by using 
normalization factor provide a relative quantity of the expressions of the genes. 
3.2.4 Microscopic analysis 
3.2.4.1 Phase contrast microscopy 
Cells were followed during the cultivation by using phase contrast microscope and 
camera system (Axiovert 25 Zeiss & AxioCam Icc). The cells were visible in cell 
culture flasks, therefore no further fixation and staining process were applied. 
Imaging was done under 100x magnification. 
B2M 1,829 
GAPDH 1,796 
TBP 1,722 
PPARγ 2,037 
perilipin 1,688 
ADPQ 1,765 
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3.2.4.2 Fluorescence microscopy 
For fluorescence staining DF24 cells were grown on glass coverslips which were 
seeded with 0,9 x 105 cells/ml (3ml in total) concentration and incubated with growth 
medium. After confluency, differentiation started with adipogenic differentiation 
media (Lonza). Coverslips were taken at day 0, day 5, day 7, and day 14 and fixated 
with PFA solution for fluorescence staining. For fixation, they were washed with 
PBS twice for 5 minutes and treated with 3,7% PFA solution for 10 minutes. The 
coverslips were kept at -800C until microscopy day. 
To understand adipogenic differentiation, we analyzed two different factors; the cell 
shapes and the occurence of oil droplets inside the cells. Accordingly, vimentin 
filaments were stained by using indirect fluorescence technique. It is called “indirect 
staining” because the labelling reagents does not directly bind the target proteins; in 
stead, they bind the primary and secondary antibody molecule complex which 
recognizes vimentins in this case (Table 3.8). Vimentins give green color and display 
the cell shapes in the images. 
Table 3.8: General features of antibodies. 
Primary Antibody 
Antigen Type Produced in Supplier Dilution 
vimentin polyclonal Guinea pig Progen 1:100 
Secondary Antibody 
Fluorophore Specifity Produced in Supplier Dilution 
Cy2 (Cyanine) Guinea pig Donkey Dianova 1:100 
Another factor that we stained was DNA molecules in the cell. For this purpose, we 
used Hoechst 33258 (Serva) which intercalates into DNA and emit a blue 
fluorescence light. Since this reagent binds DNA, it visualizes the nucleus in the cell. 
Thus, we can see nucleus with in a blue color. This is an important tool to distinguish 
the cell bodies. This type of staining is an example of direct fluorescence technique. 
Since adipocytes have a great capability to store oil particles, staining these cell 
components is one of the most important markers to understand adipogenesis. 
52 
 
For this purpose oil red o fluorescence dye (Fisher Scientific) was used. This 
molecules interacts with triglycerides in cell culture, regardless if they are in the cell 
or outside and give red points at the image. General outline of staining is listed in 
Table 3.9. 
Table 3.9: Staining protocol. 
1. Fixated cells on coverslips were rehydrated in PBS 
2. They were treated with 0,4% BSA for 15 min. And rinsed in dH2O 
3. Following treatment was made with primary antibody (1:100) for 2 hours at 
RT in dark 
4. Coverslips were rinsed in dH2O and washed with PBS for 3 times 
5. They were treated with 5% BSA for 15 min and rined in dH2O 
6. Following treatment was made with secondary antibody (1:100) for 1 hour at 
RT in dark. At the same time, coverslips are also treated with Cy2 and 
Hoechst (1:50) 
7. They were rinsed in dH2O and washed with PBS for 3 times for 10 min. 
8. Coverslips were incubated in ORO Working solution for 30 min. in dark 
9. They were rinsed in dH2O for 3 times for 30 sec. 
10. Eventually coverslips were rinsed under running tap water for 10 min. 
11. Coverslips were mounted on microscope slides and let dry in dark 
Fluorescence staining is analyzed with Leica DM-R epifluorescence device. The 
basic parameters about imaging are mentioned at Table 3.10. 
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Table 3.10: Imaging parameters. 
Component Color Fluorophore Exposure time 
DNA (nucleus) blue Hoechst ~120 ms 
vimentin green Cy2 ~650 ms 
Oil particles red oil red O ~200 ms 
Scale bar : 100 µm 
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4. RESULTS & DISCUSSIONS 
4.1 Gene expression analyses of adipogenic differentiation 
4.1.1 Establishment of cell cultures 
Two mesenchymal stem cell strains derived from bone marrow, one from adipose 
tissue and one dermal fibroblast culture were provided by Karen Bieback and 
colleagues from Institute of Transfusion Medicine and Immunology, Medical Faculty 
Mannheim, University of Heidelberg. Cell cultures for adipogenic differentiation 
were initiated with the conditions mentioned at Table 4.1. 
Table 4.1: General features of cell cultures 
Source Cell Type Name Passage No Seeding Conc. 
Bone Marrow MSC BM72 4 2 x 104 cells/cm2 
Bone Marrow MSC BM78 4 2 x 104 cells/cm2 
Adipose Tissue MSC LA47 3 2 x 104 cells/cm2 
Forehead Dermis Fibroblast DF24 24 1,5 x 103 cells/cm2 
It took approximately 3 weeks for MSCs and 2 weeks for fibroblasts to reach to the 
postconfluency. Before the assay started, day 0 samples were taken for each sample. 
Afterwards, cells were treated with adipogenic differentiation media (AIM and 
AMM, Lonza) for 14 days. Cultures of BM72, BM78 and DF24 were established for 
samplings at day 2, 5, 7 and 14, in the case of LA47 for samplings at day 2, 5 and 14. 
In addition, cultures of cells fed just with growth media were established as controls. 
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4.1.2 Total RNA isolation results 
The yield of isolated RNAs are listed in Table 4.2, 4.3, 4.4 and 4.5 for each sample. 
Table 4.2: Isolated RNA amounts of BM72 
Samples RNA [ng/µl] 
BM72 day 0 547,6 
BM72 day 2 AD+ 485,3 
BM72 day 5 AD+ 163,4 
BM72 day 7 AD+ 409,4 
BM72 day 14 AD+ 717,9 
BM72 day 2 C 333,9 
BM72 day 5 C 515,3 
BM72 day 7 C 298,8 
BM72 day 14 C 157,9 
Table 4.3: Isolated RNA amounts of BM78 
Samples RNA [ng/µl] 
BM78 day 0 472,6 
BM78 day 2 AD+ 371,6 
BM78 day 5 AD+ 287,2 
BM78 day 7 AD+ 565,8 
BM78 day 14 AD+ 445,6 
BM78 day 2 C 350,8 
BM78 day 5 C 405,5 
BM78 day 7 C 387,7 
BM78 day 14 C 369,7 
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Table 4.4: Isolated RNA amounts of LA47 
Samples RNA [ng/µl] 
LA47 day 0 237,5 
LA47 day 2 AD+ 414,6 
LA47 day 5 AD+ 536,1 
LA47 day 14 AD+ 808,4 
LA47 day2 C 284 
LA47 day 5 C 340,1 
LA47 day 14 C 441,6 
Table 4.5: Isolated RNA amounts of DF24 
Samples RNA [ng/µl] 
DF24 day 0 53,6 
DF24 day 2 AD+ 76,7 
DF24 day 5 AD+ 68,9 
DF24 day 7 AD+ 113,2 
DF24 day 14 AD+ 183,1 
DF24 day 2 C 86,4 
DF24 day 5 C 77,4 
DF24 day 7 C 95,5 
DF24 day 14 C 124,3 
The absorbance ratio at 260 nm and 280 nm is used to estimate the purity of the RNA 
samples. All the RNA isolates display 260/280 ratios between 1,95 and 2,10 which is 
close to the theoretical value of 2,00, indicating high purity of the RNA. 
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RNA amounts 
Although the RNA amounts per se are not too informative they are reflecting to some 
extent the metabolic activity of the cells. In fact, they can give us a hint if the 
response of the cells to differentiation is reasonable or coincidental. We expect a 
close correlation among the RNAs isolated at the same sampling days from the same 
type of cells. Accordingly, RNA amounts of BM72 and BM78 were largely 
correlating, whereas was not the case for RNA samples of DF24 which represents a 
totally different cell type (Fig. 4.1). 
 
Figure 4.1: The comparison of RNA amounts isolated from different cells. The 
marks refer to the time of harvesting at day 0, 2, 5, 7 and 14. 
The amounts of RNA which emphasizes the metabolic activity via transcriptome is 
compatible between two bone marrow-derived MSCs. The curves reveal a similar 
shape in a rough calculation.  This indicates that these cells respond to adipogenic 
differentiation in a comparable manner. Most probably, until day 5 most of those 
genes are suppressed which are involved in early stages of adipogenic differentiation. 
After day 5 metabolic activity raises in the cells as well as the expression of 
adipogenic marker genes. These gene expression rearrangements may influence the 
RNA profiles resembling between the samples of the two related cell strains. This is 
further substantiated by the qRT-PCR data, but this issue will be discussed in later 
sections. On the other hand, a totally different response of DF24 can be seen. 
However, it has been anticipated and it is highly plausible that the response of MSCs 
to induction medium is much higher than in fibroblasts. Nevertheless, it is hard to 
make a reliable prediction about the differentiation capacity of the fibroblasts based 
on that graph. 
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4.1.3 Quantitative RT-PCR results 
Each sample was analyzed by qRT-PCR for expression of 3 housekeeping genes and 
3 adipogenic marker genes with determined primers. All the qRT-PCR analyses were 
performed two times for each sample; hence, there were 2 Ct values of induced and 
uninduced samples. The mean Ct values and standard deviations for all samples are 
listed at Appendix D. Normalization factors were calculated by using the raw data 
(Ct values) of housekeeping genes, averages of positive control values, and primer 
efficiencies. Conclusive gene expression results were possessed by the estimation of 
adipogenic Ct values with geNorm algorithm. 
4.1.3.1 BM72 cells 
The mesenchymal BM72 cell strain, derived from bone marrow is fully competent 
for adipogenic differentiation. Gene expression of adipogenic markers PPARγ, 
perilipin, and ADPQ in cultures of BM72 cells is shown in Figure 4.2. PPARγ which 
takes a part in almost every step of adipogenesis is expressed in high amounts 
compared to the control group (Fig. 4.2A). As previously stated in detail, this protein 
is important for growth arrest and differentiation in different aspects. Treating the 
cells with AIM triggers differentiation and synthesis of PPARγ which is stronly 
increasing until day 3. Two days of AMM treatment follow the induction step and 
this is the reason of the decrease seen at day 5. Apparently at that time point 
adipogenic differentiation was not fully established yet and dependent on the 
presence of adipogenic factors. It is known that gene expression often is regulated 
even in the manner of hours, thus an adipogenic rearrangement also might be the 
reason of this decrease in PPARγ expression at day 5. After fresuming induction the 
expression increases again reaching the top value at day 14. Of note, the time point 
day 14 follows directly AMM treatment like day 5. Consequently, the cells had 
already reached an advanced stage of adipogenic differentiation at 13 days, hence 
expression of PPARγ was no longer affected by this medium change. However, 
PPARγ is also crucial for the basal metabolism of cells and thus, we see a minimal to 
modest production of PPARγ in control groups. The peak value at day 5, declining 
again thereafter, may indicate that metabolic or general cell activity was highest then 
in cultures with control mesium. 
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Perilipin synthesis is correlated and presumably required for the production of oil 
droplets. So, under relevant conditions when the cells become capable to store oil 
droplets, perilipin expression starts. In fact perilipin is a middle-to-late marker for 
adipogenic differentiation and its expression displays a corresponding pattern (Fig. 
4.2B), showing a slight delay in comparison to PPARγ. On the other hand, perilipin 
is definitely not crucial for cell survival which is underlined by its very limited 
production in the control group.  
The gene for ADPQ is only expressed in adipocytes, representing a late marker for 
adipogenesis. In accordance with this, significant ADPQ expression was not seen 
before day 7 but it was strongly raised at day 14 whereas there was virtually no 
expression in the control group (Fig. 4.2C) 
 
  
Figure 4.2: Relative adipogenic gene expression profile in BM72 cultures. 
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Figure 4.2: (contd.) Relative adipogenic gene expression profile in BM72 cultures. 
4.1.3.2 BM78 cells 
The BM78 cells are like BM72 derived from bone marrow and consequently should 
reveal comparable changes in gene expression upon induction. Thus in general, the 
profiles of adipogenic marker expression are similar between these samples, though 
some differences in expression intensity are apparent. Since the cell lines used in this 
study were provided complying with the ethical standards, we had limited knowledge 
about the donors. Thus, the observed differences may be caused by individual factors 
such as general health conditions or donor age. 
Figure 4.3 shows the expression of the adipogenic markers PPARγ (Fig. 4.3A), 
perilipin (Fig. 4.3B) and ADPQ (Fig. 4.3C) for BM78. Despite the rather minute 
differencesto the BM72 samples, similar conclusions can be drown from both sets of 
data and therefore the comments on BM72 above are also valid for BM78. 
PPARγ expression of both samples BM72 and BM78 exhibits a pattern which is 
appropriate to adipogenic differentiation (Fig. 4.2 and Fig. 4.3A). As stated before, 
the decrease at day 5 reflects the withdrawal from induction medium, intermittant 
treatment with AMM, and indicates a still not fully committed state which reached 
later on (day 14). Perilipin expression figures the lipid droplet storage potential of the 
cells (Fig. 4.2 and Fig. 4.3B). Lastly, since the cells presumably had finished 
adipogenesis at day 14, the drastically increased expression of ADPQ meets 
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expectation for being a late marker (Fig. 4.2 and Fig. 4.3C) expression of ADPQ in 
high amounts was an expectation to come. 
 
  
 
Figure 4.3: Relative adipogenic gene expression profile in BM78 culture. 
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4.1.3.3 LA47 cells 
These adipose tissue-derived mesenchymal cells exhibit some differences in 
adipogenic gene expression in comparison to the bone marrow-derived samples 
(Figure 4.4). Nevertheless, the general outline reveals also for LA47 a high potential 
of adipogenesis. 
PPARγ expression suits expectations for adipogenic differentiation (Fig. 4.4A). 
Accordingly, after the adipogenic induction with AIM, the quantitiy of gene’s 
product raises very fast and significantly higher than in the control group. This shows 
that adipogenesis is triggered immensely for this cell strain. As observed before, 
there was a decrease at day 5 due to the cycling AIM/AMM treatment and a marked 
increase again, while in the control group PPARγ was constantly expressed at low 
levels to meet the metabolic functions of the cells. 
The expression level of perilipin increases very fast after starting adipogenic 
induction while it remains low in the control at day 2 (Fig. 4.4B). The stable 
expression levels between 0,5 and 1 indicate that these cells gain quickly the lipid 
droplet storage capability being stable for 14 days. Minimal expression in the control 
groups imply absence of adipogenic differentiation. 
ADPQ is a late marker of adipogenesis but as stated before, 14 days are enough time 
for transformation into adipocytes. Thus, during the early stage of differentaition 
there is no significant change in the minute expression levels of ADPQ, while 
expression becomes very prominent at day 14 (Fig. 4.4C) 
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Figure 4.4: Relative adipogenic gene expression profile in LA47 culture. 
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4.1.3.4 Comparison of marker expression in BM72, BM78 and LA47 cells 
PPARγ 
By the adipogenic induction, PPARγ expression is raised enormously in the cell. 
This receptor is involved in cell cycle arrest and adjustment of the metabolic 
activities of cells undergoing differentiation. Therefore, it is actively synthesized 
during the whole process of this transformation but also initially at low levels for the 
basal metabolism of adipocyte precursors. 
The relative expression of PPARγ in BM72, BM78 and LA47 complies principally 
with this statement (Fig. 4.5).  However, analysis by qRT-PCR reveals some 
significant differences in amount and kinetics of PPARγ expression. 
 
Figure 4.5: PPARγ expression levels of BM72, BM78 and LA47 during 
adipogenesis. 
Bone marrow and adipose tissue-derived MSCs are both classified as multipotent 
stem cells. They have a great potential to differentiate into various cell types. But 
regarding the data presented herein, they are not really equal in their functional 
properties. In part this may mirror initial adaptation to the different environments 
(bone marrow versus fat tissue) or due to distinct inherent traits. Thus, the inequality 
in PPARγ expression may reflect adaptational changes or different degrees of 
commitment. At day 2, PPARγ expression of LA47 is almost two times higher than 
in the other samples. At day 5, after two days of factor withdrawal, LA47 cells still 
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synthesize more PPARγ mRNA than the other cell strains. The need to survive in 
adipose tissue might have triggered this modification in response. Moreover, the 
PPARγ expression level around 1,5 at day 14 is apparently sufficient for LA47 cells, 
whereas the bone marrow-derived cells may need more expression. This is important 
because the modifications which cause the fluctuations of PPARγ gene expression 
might be the factors for the conversion of early progenitors into committed pre-
adipocytes. 
Perilipin 
There is a similar difference between bone marrow and adipose tissue-derived MSCs 
in perilipin expression as seen for PPARγ (Fig. 4.6). Perhaps, the susceptibility skills 
for adipogenesis provide this difference. Accordingly, after 3 days of adipogenic 
induction, LA47 cells express perilipin almost two times higher than the other 
samples. Furthermore, at day 5, expression is still around 0,5 for LA47 whereas there 
is virtually no expression in the bone marrow-derived samples. On the other hand, 
there is an extreme increase in BM72 and BM78 at day 14 whereas in LA47 the level 
is only moderately raised, thus showing a quite steady perilipin expression level 
throughtout. 
Perilipin is necessary to store oil droplets inside the cell. With the synthesis at day 2, 
LA47 cells start to constitute oil vesicles earlier than the other cells. The expression 
at day 5 and day 14 is needful and enough to maintain the existence of oil particles. 
On the other hand, perilipin expression in BM72 and BM78 starts after a couple of 
metabolic adaptations to adipogenesis. The ability of the cells to store oil droplets 
closely corresponds with the abrupt increase in perilipin synthesis. 
This is a very important finding because it may be explicative for the differences 
between progenitors and their progeny, the pre-adipocytes. The adipose tissue-
derived MSCs, generally accepted as pre-adipocytes have exhibited a much faster 
reaction to adipogenic induction than the bone marrow-derived MSCs which are 
considered as pre-adipocyte progenitors. This firmly underlines the view that there is 
an additional rearrangement step to reach a stage corresponding to adipose tissue-
derived adipocyte precursors. 
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Figure 4.6: Perilipin expression levels of BM72, BM78 and LA47 during 
adipogenesis. 
Adiponectin 
Adiponectin (ADPQ) is a marker for advance adipogenesis, therefore the relatively 
late expression, being very strong at day 14 fits into that scheme (Fig. 4.7). This is an 
expressive finding for the potential of these cell strains to undergo adipogenesis. 
 
Figure 4.7: Perilipin expression levels of BM72, BM78 and LA47 during 
adipogenesis. 
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Nevertheless the reason is elusive why ADPQ expression is too much higher in the 
bone marrow-derived samples than in LA47 which is completely against expectation. 
But the following theoretical approach may enlighten this paradox. 
As discussed before, though we accept all the MSCs as multipotent stem cells, the 
classification of these cells needs a more detailed system. For example, we observe 
the adaptation to the adipogenic induction in LA47 faster than in BM72 and BM78 
according to PPARγ and perilipin expression. These factors are important for 
adipogenesis and the regulation of other intracellular processes. They do not serve as 
signal molecules between the cells, while adiponectin protein serves as a adipocyte-
derived hormone in the organism. Therefore we can suppose that adiponectin is 
important for the missions of the adipocytes but not for their own maintenance in the 
first place. 
Today we accept adipose tissue as an endocrine organ. On the other hand, adipocytes 
are found in different regions of the body such as bone marrow. The thing is, MSCs 
from different regions of the body might be modified in a different manner. The 
adipocytes in bone marrows might assume more regulatory duties comparing with 
adipose tissue-resident fellows which mostly focus on lipid storage. Thus, the high 
adiponectin expression in BM72 and BM78 at day 14, far exceeding that of LA47, is 
presumably not directly related to intimate adipogenic function. 
Conclusion 
The results of relative gene expression demonstrated that MSCs from both bone 
marrow and adipose tissue were capable for complete adipogenic differentiation. 
Whereas BM72 and BM78 cells revealed similar gene expression profiles, the profile 
of the LA47 sample was slightly different. In the samples from bone marrow MSCs 
we could not observe significant changes in gene expression initially, but an increase 
at day 7 with further enhancement at day 14. Contrarily, in the samples from adipose 
tissue MSCs, we observed a higher expression of adipogenic marker genes at the 
beginning of adipogenic induction, while at day 7 and 14 expression raised only 
modestly, being lower than in BM72 and BM78. Considering all these cells alike 
multipotent stem cells, which they were actually supposed to be, then what might be 
the reason for these differences in expression? While this issue remains still elusive, 
the findings on individual expression of the adipogenic markers, provide some clues 
for this question. Since PPARγ is important in regulation of adipogenesis, the high 
69 
 
PPARγ expression score of LA47 at day 2 indicates a quicker response to adipogenic 
stimuli. Later on these cells might need less amounts of this protein to further 
proceed in adipogenesis. This is apparently also the case for perilipin. 
On the other hand, ADPQ is a late marker of adipogenic differentiation and thus its 
expression had to be looked at especially on day 14 which gave relative expression 
scores of 0,7 – 2,5 – 2,1 LA47, BM72, and BM78 in that sequence. Hence, the scores 
of the BM samples are at least three times higher than that of the LA sample which 
strongly suggests that they represent two distinct subtypes [160]. 
In human, generally there two types of bone marrow: Red bone marrow and yellow 
bone marrow. Red marrow is basically responsible to produce blood cells. Yellow 
marrow is referred as yellow because of the existence of adipocytes in this tissue. 
Though yellow bone marrow is not directly related with hematopoiesis, the 
signalling and immunomodulatory factors secreted primarily from adipocytes and 
other cells in this tissue contributes to this mechanism. Besides, yellow marrow 
contains MSCs in abundance. These multipotent stem cells can differentiate into a 
number of cell types icluding especially osteoblasts and adipocytes. 
Adiponectin is an essential hormone for the organism produced by adipocytes, 
playing an important regulatory role for the energy metabolism. Moreover, it is 
controlling adipogenesis and can function as suppressor function. After full 
maturation, adipocytes yellow bone marrow, derived from MSCs start to synthesize 
ADPQ which upon a certain level prevent adipogenesis of neighbouring stem cells. 
Thus, excessive fat cell production in marrow is suppressed. The lower levels of 
ADPQ in adipose tissue could explain that adipogenesis is not limited as much as in 
bone marrow, which is compatible with the observed differences in our MSC 
samples. 
4.1.3.5 DF24 cells 
The fibroblast line DF24 was investigated for its adipogenic differentiation capacity 
by determining the expression of PPARγ, perilipin and adiponectin (ADPQ) after 
adipogenic induction. The cells were treated with adipogenic induction and 
adipogenic maintenance medium using alternating induction cycles as for the MSC 
cells. The data of relative gene expression are given in Figure 4.8. 
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Expression of PPARγ is increasing immediately under the treatment with induction 
medium over 14 days as seen for MSCs (Fig. 4.8A), while the basal expression 
remains rather low throughtout in the range between 0.2 and 0.3. Under the influence 
of induction, expression levels raise to 0.7 or 0.8 at day 2 and 5, reaching a peak of 1, 
at day 7 (7 times higher than the basal levels) with a modest decline at day 14. This 
clearly demonstrates that also the DF24 cells, though representing fibroblastic 
lineage, are able to respond to adipogenic induction by increased expression of this 
early marker. 
Also expression of perilipin was inducible in DF24 by adipogenic induction, as 
demonstrated by the sharp increase at day 7 (Fig. 4.8B). Similar to PPARγ, there was 
a mild decrease observed at day 14. Accordingly, DF24 cells started to form oil 
vesicles inside which, however remained restricted in size.  
While the control group is cultivated in growth medium with a high content of 
glucose, the adipogenic induction medium contains in addition insulin, IBMX, and 
dexamethasone, which trigger adipogenic differentiation in MSC cultures. While 
insulin stimulates glucose intake, IBMX stimulates cAMP production which is a 
crucial promoter for adipogenesis in MSCs. But the point is that not every event in 
this scenario does have the same consequences in another cell type. Thus, cells can 
adapt to these new conditions without undergoing cellular differentiation. 
Accordingly, DF24 cells were storing small oil droplets in response to these factors 
without proceeding further in this specific type of differentiation. Confirming  
proposition, the late differentiation marker ADPQ was not at all expressed in  DF24, 
neither in growth nor in adipogenic induction medium in contrast to matured 
adipocytes. 
These findings document that some rearrangements in gene expression occur in 
dermal fibroblasts (DF24) under the influence of adipogenic factors. However, cells 
seem not to respond to this stimulus with a regular adipogenic program which was 
underlined by further investigations using a different approach (see below). 
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Figure 4.8: Relative adipogenic gene expression profile of DF24 culture. 
 
 
 
0
0,5
1
1,5
2
2,5
3
d0 d2 d5 d7 d14
R
e
la
ti
v
e
 E
x
p
re
ss
io
n
PPARγ
AD
C
A
0
0,5
1
1,5
2
2,5
3
d0 d2 d5 d7 d14
R
e
la
ti
v
e
 E
x
p
re
ss
io
n
perilipin
AD
C
B
72 
 
4.2 Immunofluorescence staining of DF24 for adipogenic markers 
4.2.1. Cultivation on coverslips and adipogenic differentiation 
For better understanding of the adipogenic differentiation potential of DF24 cells, 
they were analyzed by immunofluorescence staining in parallel to gene expression 
assays. For this purpose, DF24 cells of passage 24 were suspended at a density of 0,9 
x 105 cells/ml and 3 ml were seeded on 6 cm cell culture dishes with glass coverslips. 
Adipogenic differentiation was stimulated after the cells reached confluency, using 
the same protocol as for the gene expression. Accordingly, cells were treated for 3 
days with AIM, followed by 2 days in AMM, which was repeated two more times. 
Treated and control cells were sampled at day 0, 2, 5, 7, and 14. After fixation of the 
specimens, coverslips were stored at -300C until analysis. 
4.2.2 Following the fibroblasts exposed to adipogenic factors 
Taken as reference, the image of an MSC-derived adipocyte culture exhibits a closed 
layer of largely spherical shaped cells, partially overlapping (Fig. 4.9). Accordingly, 
morphological changes of DF24 cells were followed during treatment with  
adipogenic medium by phase contrast microscopy (for methods by Axiovert 25 Zeiss 
Microscope and AxioCam Icc 1 camera system). The comparison of treated and 
control cultures of DF24 is presented in Figure 4.10. 
  
 
Figure 4.9: Human adipocyte cell culture (www.cellapplications.com). 
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Generally, ~80% confluency of cultures is sufficient to initiate differentiation. But, 
despite the subconfluency, infrequent mitoses were noted from time to time among 
the control group cultures. Accordingly, cells supressed partially their active 
proliferation, though an increase in density was observed, while maintaining their 
spindle-shaped structure. Any abnormal events such as contamination or necrosis 
were not reported during the treatment. 
The adipogenic factor treated group revealed some alterations through adipogenic 
treatment, however, these variations were limited only to individual groups of cells. 
Thus, from day 5 some cell accumulations appeared resembling somehow clusters of 
adipogenic cells at that state. While eventually most cells became less elongated, cell 
bodies acquired a more roundish shape. This type was maintained through day 14, 
but no further morphological transformations could be observed which would have 
been indicative for adipogenic differentiation process. 
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Figure 4.10: Phase contrast microscopy of adipogenic induced and control DF24 
cells. Left panel shows control samples cultivated in complete growth 
medium whereas the right column cells cultivated under adipogenic 
stimuli. 100x mag. 
Day 0 BM-MSC day 14 AD 
Day 2 C Day 2 AD 
Day 5 C Day 5 AD 
Day 7 C Day 7 AD 
Day 14 C Day 14 AD 
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 4.2.3 Immunofluorescence staining 
DF24 cells were analyzed  for the formation of lipid droplets as morphological 
indicator of adipogenic differentiation by immunofluorescence staining, in 
comparison to gene expression. For evaluation of integrity and cellular shape, also  
vimentin, a typical cytoskeletal component in mesenchymal cells, was visualized by 
fluorescence staining and in addition cell nuclei by Hoechst DNA-stain. The changes 
during treatment are shown in Figure 4.11. 
At day 7, initiation of a slight accumulation of fat vesicles can be seen, which 
becomes very pronounced at day 14. This type of distribution is also oberved in 
multilocular cells like brown fat adipocytes. This finding also corresponds to the 
gene expression data. As a reminder, expression of perilipin which is essential for oil 
particle formation has started at day 7 and remained until day 14. Thus what we see 
in the images fits to these findings. On the other hand, we observed a progression 
from spindle to spherical shape also by immunofluorescence staining. 
Though there are findings that would support in vitro adipogenesis, we could not get 
a definite proof that dermal fibroblasts initiate and proceed in this type of 
differentiation. Therefore, we believe that these cells can realize some structural and 
genetic rearrangements under adipogenic stimuli, however, terminal adipogenic 
differentiation seems far from being realized. 
 
 
 
 
 
 
 
 
 
 
 Figure 4.11: Immunofluorescence staining images of DF24.
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4.3 Adipogenic differentiation on ECM proteins coated surface 
Culture flasks were coated with ECM proteins as described in methods. In previous 
work the bone marrow-derived mesenchymal stem cells used herein had been 
demonstrated to possess high potential for adipogenic differentiation. Thus, we chose 
BM72 cells (passage 6) for this assay using a seeding density of 2 x 104 cells/cm2. A 
general outline about cultivation conditions is provided in Table 4.6. 
4.3.1. Preparation of cell cultures and RNA isolation 
Culture flasks were coated with ECM proteins with the methods noted in related 
section. In previous work, bone marrow-derived mesenchymal stem cells were 
examined about their adipogenic differentiation skills and they exhibited a high 
capacity of adipogenesis. Thus we chose BM72 samples for this assay. According to 
this purpose, we use passage 6 BM72 cells with 2 x 104 cells/cm2 seeding 
concentration. General information about cultivation of the cells are noted in Table 
4.6. 
Table 4.6: General features of cell cultures on coated surface. 
Coating protein Sample Passage No Seeding Conc. 
Collagen type I BM72 6 2 x 104 cells/cm2 
Collagen type IV BM72 6 2 x 104 cells/cm2 
Fibronectin BM72 6 2 x 104 cells/cm2 
Laminin BM72 6 2 x 104 cells/cm2 
Null [PBS] BM72 6 2 x 104 cells/cm2 
 
Total RNA isolation results of BM72 cultures are listed in Table 4.7. 
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Table 4.7: Isolated RNA amounts of samples. 
Sample ng/µl 
BM72 d0 Col1 GM 34,8 
BM72 d0 Col4 GM 29,1 
BM72 d0 FN GM 23,5 
BM72 d0 LN GM 41 
BM72 d0 PBS GM 34 
BM72 d2 Col1 GM 68,8 
BM72 d2 Col1 AIM 61 
BM72 d2 Col4 GM 73,7 
BM72 d2 Col4 AIM 132,1 
BM72 d2 FN GM 58,8 
BM72 d2 FN AIM 42,8 
BM72 d2 LN GM 86,5 
BM72 d2 LN AIM 126,2 
BM72 d2 PBS GM 61,6 
BM72 d2 PBS AIM 105,2 
BM72 d5 Col1 GM 73,2 
BM72 d5 Col1 AIM 15,3 
BM72 d5 Col4 GM 76,1 
BM72 d5 Col4 AIM 22,2 
BM72 d5 FN GM 82,6 
BM72 d5 FN AIM 19,3 
BM72 d5 LN GM 58,3 
BM72 d5 LN AIM 14,2 
 BM72 d5 PBS GM 50,9 
BM72 d5 PBS AIM 57 
BM72 d7 Col1 AIM 135,6 
BM72 d7 Col4 AIM 71,1 
BM72 d7 FN AIM 118,9 
BM72 d7 LN AIM 89,7 
BM72 d7 PBS AIM 66,8 
     BM72 d14 Col1 GM 49,1 
BM72 d14 Col1 AIM 180,3 
BM72 d14 Col4 GM 64,8 
BM72 d14 Col4 AIM 14,1 
BM72 d14 FN GM 42,9 
BM72 d14 FN AIM 218,6 
BM72 d14 LN GM 94 
BM72 d14 LN AIM 28,9 
BM72 d14 PBS GM 62,2 
BM72 d14 PBS AIM 14,5 
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The cells were cultivated under adipogenic stimuli for 14 days. After the cells 
reached to postconflueny, differentiation was initiated and sampling was done at day 
0, 2, 5, 7, and 14. Isolated RNA amounts and 260/280 ratios were measured by 
Nanodrop ND 1000 V 3.3 spectrophotometer system (Thermo Scientific) which 
revealed a high RNA purity by general ratios around 2,05. However, a marked 
restriction in RNA production (or recovery) was observed over time, though the 
reason of this remains unclear. 
4.3.2. Phase contrast images of adipogenic induction on ECM coated surfaces 
All MSC cultures were followed up during 14 days of adipogenic treatment by phase 
contrast microscopy. The effects of the applied ECM proteins are shown in the 
following figures. 
Control Group: 
Day 2           Day 5       Day 14 
 
Adipogenic Group: 
Day 2           Day 5       Day 14 
  
100x magnification – uncoated  
Figure 4.12: Morphological changes of BM72 cells after adipogenic induction 
cultivated without surface coating. Phase-contrast 100x mag. 
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The successful induction of adipogenic differentiation in cultures without coating is 
demonstrated in Figure 4.12. The profound changes in cell shape and dense 
accumulations of oil particles at day 14 are strong evidence for an advanced stage in 
adipogenesis. In contrast, MSCs cultivated with growth medium maintained their 
initial cellular characteristics during the assay as expected. 
Control Group: 
Day 2           Day 5       Day 14 
   
Adipogenic Group: 
Day 2           Day 5       Day 14 
   
100x magnification – collagen type I 
Figure 4.13: Morphological changes of BM72 cells after adipogenic induction 
cultivated on collagen type I coated surface. Phase-contrast 100x mag. 
Considering the endpoints day 14 of the adipogenic groups at day 14, we can state 
that all coatings revealed similar effects on adipogenesis, being rather modest at best. 
Only the effect of collagen type I (Figure 4.13) seemed to be slightly stronger, while 
on laminin coating the shape changes became apparent somewhat earlier, clearly 
visible at day 2 (Figure 4.16). This shows that phase contrast images allowed only a 
limited evaluation. 
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Control Group: 
Day 2   Day 5          Day 14 
   
Adipogenic Group: 
Day 2    Day 5           Day 14 
   
100x magnification – collagen type IV 
Figure 4.14: Morphological changes of BM72 cells after adipogenic induction 
cultivated on collagen type IV coated surface. Phase-contrast 100x 
mag. 
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Control Group: 
Day 2           Day 5       Day 14 
   
Adipogenic Group: 
Day 2           Day 5        Day 14 
   
100x magnification - fibronectin 
Figure 4.15: Morphological changes of BM72 cells after adipogenic induction 
cultivated on fibronectin coated surface. Phase-contrast 100x mag. 
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Control Group: 
Day 2           Day 5       Day 14 
   
Adipogenic Group: 
Day 2           Day 5       Day 14 
   
100x magnification - laminin 
Figure 4.16: Morphological changes of BM72 cells after adipogenic induction 
cultivated on laminin coated surface. Phase-contrast 100x mag. 
Collectively, BM72 cells were able to terminally differentiate regardless of the 
proteins that we have used to coat the surface. However, as stated before, this 
evaluation by phase contrast allows only a very crude prediction of the effects of the 
ECM proteins on differentiation behavior. Thus, more conclusive resutls should be 
gained by relative expression analysis of adipogenic marker genes. 
4.3.3. Influence of ECM coating on relative gene expression 
Expression of the adipogenic marker genes PPARγ, perilipin, and ADPQ was 
analyzed as shown before, providing a quantitative estimation of the effects of these 
ECM proteins on adipogenesis. The qRT-PCR analysis of all samples was carried out 
using the same housekeeping genes and primers as in the previous assays. The 
mathematically calculated relative expression is presented in this section for every 
coated surface. 
 Figure 4.17: Kinetics of PPARγ expression 
induction, grown on 
Figure 4.17 shows that on all 
similar amounts of PPARγ which is 
However, with time significant differences become apparent among the samples 
cultivated on different ECM proteins. 
approve a proper application 
started and the levels of PPARγ 
changes at day 5. In marked contrast, 
ECM proteins were beginning to exert marked 
accord with the positive regulatory effects of fibronectin 
laboratories (-mentioned in Introduction
mechanisms such as wound healing, vascular development or cell growth in 
organism. Therefore, this finding complies with our expectations. 
though less pronounced was the effect of c
protein in the majority of ECMs and also the whole vertebrate organism
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of BM72 cells after adipogenic 
different protein coatings. 
ECM protein coatings BM72 cells express initially 
essential factor for early steps in adipogenesis. 
In detail, the similar expression levels at day 2
of the assay. In these cultures treatment has 
mRNA are almost the same showing only marginal 
at day 7, after 6 days of adipogenic induction, 
effects on PPARγ expression, in 
reported by other 
). This ECM protein involves to a series of 
Also strong, 
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 surrounded by this protein in their habitat
by this protein. This is compatible with the niche concept for MSCs or derived 
precursor cells, ‘feeling more comfortable’ in such type of microenvironment. Like 
fibronectin the existence of c
though with some delay, reflected by a
presence of ECM, while 
collagen type I which indicates a diverse ECM specificity in the angiogenic process
Figure 4.18: Kinetics of perilipin expression of BM72 cell
induction, grown on different protein coatings
Perilipin serves important functions in regulation of lipid sto
metabolism in the cells. It is essential for lipid droplet formation. Thus it is one of the 
most characteristic proteins of adipocytes
The data on relative gene expression
stimulate perilipin sy
frame and intensity as demonstrated for 
supports adipogenic differentiation through perilipin production, 
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 and kept in place without being 
ollagen type I may favor adipogenic differentiation, 
 higher expression of PPARγ
the most effective protein is fibronectin
s
 
. 
 indicate that fibronectin and collagen type I 
nthesis in BM72 cells (Fig. 4.18). This occurs in a similar time 
PPARγ. Thus, fibronectin 
ay 7 and still about two times higher at day 14. In 
aminin and collagen type IV do not seem to have any 
d5 d7 d14
stimulated 
 synthesis in the 
, followed by 
. 
 
 after adipogenic 
rage and lipid 
obviously 
so does collagen 
Col I
Col IV
FN
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Null
 positive influence on adipogenic processes, not even detectable at day 14. 
type IV gave a relatively lower 
difference was too low to be significant for implying a modest 
conclude, fibronectin and collagen type I exert
attributed to perilipin expression, where
neutral in the aspect. 
Figure 4.19: Kinetics of ADPQ expression of BM72 cell
induction, grown on different protein coatings
Adiponectin (ADPQ) is a late marker of adipogenesis, 
significant expression of this gene is 
raising until day 14. As seen for the other genes above, 
influenced by ECM proteins in different ways.
At day 2 and day 5 there is 
produce minimal levels of ADPQ. At day 7, 
showing slightly higher ADPQ 
means once more that cells on fibronectin advance faster
differentiation than cells on the other ECM proteins.
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expression score for perilipin indeed,
suppressive effect
 positive differentiation stimuli 
as laminin and collagen type IV are the best 
s after adipogenic 
. 
which explains again that 
not observed before day 7, which is further 
ADPQ synthesis is 
 
virtually no ADPQ expression, at best at day 5 cells 
some differences become 
mRNA levels especially for fibronectin samples. This 
 in a
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At day 14, adiponectin mRNA levels reach the top, showing that primarily 
fibronectin and, consistently second place, collagen type I supports synthesis of 
ADPQ like that of the other marker genes. With this adequate finding, the notion that 
both proteins supports adipogenic differentiation becomes irrefutable. Whereas the 
maximal stimulation by collagen type I is only about 30% lower than by fibronectin, 
coating with collagen type IV or laminin results in similar ADPQ expression profiles 
as on plain dishes as seen before for perilipin synthesis. 
Collectively, fibronectin primarily but also collagen type I apparently provide 
suitable support for long-lasting adipogenic differentiation of MSCs, at least for 
populations derived from bone marrow. 
As final critical synopsis of experimental work, it has to be pointed out again that the 
results of these qRT-PCR data are relative. In every single reaction, the expression 
level of regular/current house keeping genes is employed as basic internal standard. 
In the first series of qRT-PCR reactions, the results of fibroblast and MSCs derived 
from different tissues were added to the calculation of normalization factors. On the 
other hand, in the second round of qRT-PCRs, only BM72 cells were analyzed, 
growing on different coated surfaces or without ECM coating. The important thing is 
that the lower scores of this second set of reactions, exhibiting relatively lower 
grades, do not mean these cells express lower amounts of adipogenic markers. 
Conclusion 
According to the results of relative gene expression analysis, fibronectin was found 
as the most effective protein even more than collagen type I. But interestingly, at day 
2, expression was even lower on collagen type I and fibronectin, implying a delayed 
onset of differentiation. The cells cultured on fibronectin-coated surface gave an 
average of 24 Ct values at day 14 for three marker genes with a maximum ratio of  
0,04 standard deviation. Day 14 results of fibronectin group and control group are 
given at Figure 4.20. 
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Table 4.8: Relative gene expression results of FN, Col IV and control groups at day 
14 
Day 14 PPARγ perilipin ADPQ 
fibronectin 1,50 1,50 1,50 
collagen type IV 0,71 0,30 0,14 
no coating 0,33 0,37 0,16 
Considering these results we can state that fibronectins strongly induce adipogenic 
differentiation. After fibronectin, collagen type I protein was found to be the most 
effective. Comparing with control group results, expression levels of marker genes 
increased approximately threefold at day 14. Laminin protein showed a relatively 
neutral characteristic, the results were very similar with control group. 
A marked effect of the ECM proteins collagen type IV and laminin was clearly 
restricted to PPARγ expression and only seen at the late phase (two times higher than 
control), So this should not be related to adipogenesis and reflect other PPARγ 
functions. Day 14 results of collagen type IV group and control group are also given 
at Figure 4.20. Decreases are occured in very small rates. Therefore, an inference 
through the inhibitory effects of collagen type IV on adipogenic differentiation 
would not be healthy. This protein also demonstrates relatively neutral effect on 
adipogenesis like laminin protein. 
Both experiments were done with BM72 cell strain. In the second assay, the group 
cultivated on no coating has had the same conditions with the cells at the first assay. 
The only difference was that ECM proteins investigation was carried out with 2 
passages older cells (p6). This is an important situation because since these are 
primary cell strains and naturally tend to be very sensitive, it is hard to foresee their 
behaviors in invitro environment. Therefore, their comparison also done as the last 
step of the thesis, by using their Ct values and internal control house-keeping genes. 
Results are given at following figures. 
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Figure 4.20: Comparison of passage 4 and passage 6 BM72 cells under adipogenic 
induction due to their relative gene expression results 
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Figure 4.20: (contd.) Comparison of passage 4 and 6 BM72 cells under adipogenic 
induction due to their relative gene expression results 
As observed, BM72 cells tend to lose their differentation capacity after two times of 
passaging. In this context, fibronectin and collagen type I, as the abundant proteins of 
bone marrow matrix, assist to the cells to keep their high differentiation capacity. On 
the other hand, collagen type IV and laminin are among the basic proteins of 
basement membrane which is not a part of bone marrow ECM, thus the 
mesenchymal stem cells cultivated on these proteins showed a decrease in their 
differentiation potential curve as the cells cultivated without any coating. To 
conclude, comparison of gene expression results of passage 4 and 6 BM72 cells 
cultivated with the same conditions might mean that collagen type I and fibronectin 
proteins accomplish a partial rescue of adipogenic differentiation. 
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5. CONCLUSION 
Though there was a minimum level of PPARγ expression in MSC control groups, we 
witnessed an excessive increase in the PPARγ expression of the cells treated with adipogenic 
induction. Meanwhile, we observed a reaction in induced fibroblasts but the effects were 
lighter in comparison with MSCs. Like PPARγ expression profile, perilipin expression was 
also seen among the cell types, nevertheless factor dependent skills of this protein points to 
an adaptational rearrangement more than being a differentiational process. MSC samples 
expressed high amount of ADPQ, a late marker of adipogenesis, whereas we could not 
observe any expression of ADPQ in fibroblasts. High adipogenic differentiation potential of 
MSCs were obvious, however, qRT-PCR results revealed some significant differences in 
kinetics of the adipogenic marker gene expressions. As it is known, all MSCs are classified 
as multipotent stem cells, but regarding the data herein; they were not equal in their 
functional properties. This inequality in gene expressions may reflect different degrees of 
commitment and would be explicative for the conversion of early progenitors into committed 
pre-adipocytes. 
Fibroblasts, on the other hand, needed to be confirmed by further assays including 
immunofluorescence staining and cell proliferation kinetics. Accordingly, we could not 
observe any particular change in cell cultures neither for induced group nor control group in 
phase-contrast microscope images. Closer immunofluorescence staining images revealed a 
more round cell shape which was normally elongated for fibroblasts, and occurrence of oil 
vesicles was in correlation with gene expression analysis. Eventually, we believe that though 
fibroblasts have shown a high adipogenic adaptation capability, they were far from true 
adipogenesis. 
As demonstrated for bone marrow MSCs, fibronectin and collagen type I promote/maintain 
adipogenesis, possibly also by expansion of intermediate precursor cells, presumably a 
crucial aspect for homing and tissue repair and regeneration. In contrast, laminin and 
collagen type IV, being neutral in this respect, are likely candidates for providing a genuine 
docking site for MSC maintenance in bone marrow or perivascular location. Further studies 
on this subject would be highly rewarding for tissue engineering and translational medicine. 
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APPENDIX A 
Laboratory Equipment 
 
Micropipettes  Eppendorf Research 2µl 10µl 20µl 100µl 200µl 1000µl 
Pipettes    Sarstedt Serological Pipettes 2 ml, 5 ml, 10 ml, 25 ml 
Multipipette   Eppendorf Multipette stream + Combitips 
Centrifuge    Hettich ROTINA 420 Tabletop Centrifuge 
Minicentrifuge  Eppendorf Centrifuge 5415 D 
Eppendorf Minispin Plus 
    Labnet Minicentrifuge 
Vortex    IKA MS3 Basic & Yellowline TTS2 
Balance    Kern Scales 440 
Microwave   Clatronic MW 771 
Water Bath   Medingen Water Bath WBT22 
Laminar Flow  Thermo Scientific HERAsafe Cabinets Class II 
Incubator    Thermo Scientific Heraeus Function Line 
Refrigerators   Liebherr +40C, FRYKA -300C, Kirsch -300C 
New Brunswick Scientific -800C 
PCR Thermocyclers  Bio Rad DNA Engine Dyad Peltier Thermal Cycler 
    Eppendorf Mastercycler Thermal Cycler 
Spectrophotometer  Thermo Scientific Nanodrop ND 1000 V 3.3 
+ Software 
Cell Counter   Beckman Coulter Vi-Cell XR Cell Viability Analyzer 
+ Software 
qRT-PCR System  Roche LightCycler 480 Real-Time PCR System 
    Software + geNorm algorithm data calculation 
Autoclave    Systec V-150 
Heat Sterilizator  Jouan Oven 
Microscope   Axiovert 25 Zeiss + AxioCam Icc 1 + Software 
Epifluorescence  Leica DM-R 
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APPENDIX B 
Kits & Chemicals 
 
Disinfectants   Bacillol AF - Cellculture 
    Applichem RNase-ExitusPlus 
Ethanol    Carl Roth 70%, 99,9% (RNA purpose) 
Trypsine    PAA 
PBS    PAA Dulbecco’s PBS (1x) without Ca & Mg 
β-mercaptoethanol  Applichem β-mercaptoethanol (RNA purpose) 
DMEM    PAA DMEM High Glucose (4,5g/L) with L-Glutamine 
FCS    Invitrogen 
Penicillin/Streptomycin Biochrom 
Differentiation Media Lonza Adipogenic Induction Medium 
    Lonza Adipogenic Maintenance Medium 
Collagen type-I  Roche 
Collagen type-IV  Sigma-Aldrich  
Fibronectin   Roche 
Laminin    Roche 
Paraformaldehyde  Sigma-Aldrich 
BSA    Roche 
Primary Antibody  GF53 – Vimentin specific, Progen Biotechnik 
Secondary Antibody  Dianova cat# no 706-226-148 
Fluorophore   Cyanine Dye 2 (Cy2),  Serva 
Fluorophore   Hoechst 33258, Serva 
Lysochrome   Oil red o, Fisher Scientific cat# no 50-121-0480 
RNA Isolation  Qiagen Rneasy Kit 
RT Reaction   Roche Transcriptor High Fidelity cDNA Synthesis Kit 
qRT-PCR    Roche LightCycler 480 Probes Master (2 Conc.) 
Probes    Roche Diagnostics Universal ProbeLibrary 
Primers    Sigma-Aldrich 
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APPENDIX C 
Buffers & Media 
 
Growth Medium  500ml DMEM HighGlucose (4,5g/L) with L-
Glutamine 
    50 ml FCS 
5ml 100x Penicillin/Streptomycin 
 
Differentiation Media Adipogenic Induction Medium  
(AIM) - Complete Kit 
    Lonza AIM, h-insulin, L-glutamine, MCGS, 
Dexamethasone, Indomethacin, 
IBMX (3-siobuty-1-methyl-xanthine), 
GA-1000 
 
Adipogenic Maintenance Medium 
(AMM) – Complete Kit 
Lonza AMM, h-insulin, L-glutamine, MCGS, 
GA-1000 
 
Trypsine Solution  Trypsin/EDTA (0,025% / 0,01%) 
Trypsin 125 mg, EDTA 50 mg 
500 ml HBSS 
 
PFA Solution   7,4 g PFA (3,7% last concentration) 
    200 ml PBS pH 7,4 (Dissolve @700C) 
 
BSA Blocking Solution 0,1 g BSA (0,1% last concentration) 
    100 ml PBS pH 7,4 
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APPENDIX D    -     Mean Ct and Standard Deviation Values of Samples 
Genes ADPQ B2M GAPDH perilipin PPARγ TBP 
Samples                      Values Ct sd Ct sd Ct sd Ct sd Ct sd Ct sd 
BM72 p4 day 0 - - 23,51 0,24 22,14 0,06 37,22 0,35 29,34 0,14 28,22 0,36 
BM72 p4 day 2 AD 33,00 0,03 23,41 0,15 22,49 0,04 29,10 0,00 26,23 0,01 29,57 0,34 
BM72 p4 day 5 AD 36,45 0,01 21,32 0,07 21,24 0,09 34,84 0,07 25,68 0,01 28,16 0,05 
BM72 p4 day 7 AD 26,10 0,01 22,62 0,07 20,94 0,05 26,39 0,06 25,28 0,07 29,06 0,06 
BM72 p4 day 14 AD 23,43 0,01 23,45 0,03 21,92 0,04 24,81 0,00 24,40 0,01 28,84 0,06 
BM72 p4 day 2 C - - 23,53 0,02 22,36 0,03 37,51 0,22 28,95 0,03 29,57 0,01 
BM72 p4 day 5 C 31,90 0,02 23,93 0,01 22,38 0,04 30,99 0,11 27,70 0,02 30,27 0,05 
BM72 p4 day 7 C - - 22,80 0,00 20,96 0,06 - - 29,11 0,04 31,18 0,02 
BM72 p4 day 14 C 36,81 0,47 22,93 0,05 21,65 0,03 37,13 014 29,32 0,09 28,10 0,02 
Genes ADPQ B2M GAPDH perilipin PPARγ TBP 
Samples                      Values Ct sd Ct sd Ct sd Ct sd Ct sd Ct sd 
BM78 p4 day 0 - - 24,04 0,01 22,32 0,04 - - 30,99 0,06 28,96 0,01 
BM78 p4 day 2 AD 24,61 0,03 23,45 0,42 22,02 0,01 30,25 0,01 26,74 0,01 29,84 0,02 
BM78 p4 day 5 AD 37,93 0,02 21,94 0,05 21,53 0,04 35,51 0,10 26,96 0,01 28,80 0,05 
BM78 p4 day 7 AD 29,31 0,09 23,90 0,01 22,05 0,04 28,63 0,01 27,46 0,01 30,37 0,06 
BM78 p4 day 14 AD 23,64 0,05 23,67 0,01 21,59 0,04 24,92 0,01 24,85 0,04 28,58 0,02 
BM78 p4 day 2 C - - 22,92 0,04 21,98 0,01 - - 29,84 0,07 29,49 0,03 
BM78 p4 day 5 C 34,45 0,14 23,13 0,02 20,88 0,03 33,93 0,09 27,85 0,00 29,31 0,08 
BM78 p4 day 7 C - - 23,89 0,13 22,36 0,04 - - 31,01 0,10 29,37 0,22 
BM78 p4 day 14 C 37,99 0,22 23,68 0,01 21,86 0,03 36,87 0,17 30,77 0,23 28,64 0,12 
110 
 
Genes ADPQ B2M GAPDH perilipin PPARγ TBP 
Samples                      Values Ct sd Ct sd Ct sd Ct sd Ct sd Ct sd 
LA47 p3 day 0 - - 23,82 0,01 22,82 0,02 - - 29,05 0,02 28,89 0,05 
LA47 p3 day 2 AD 30,79 0,01 23,10 0,01 22,88 0,02 27,31 0,05 25,04 0,02 28,73 0,04 
LA47 p3 day 5 AD 30,24 0,03 23,56 0,01 22,90 0,04 28,41 0,06 26,47 0,05 28,99 0,11 
LA47 p3 day 14 AD 25,87 0,17 23,54 0,02 21,84 0,13 27,07 0,01 25,25 0,03 29,36 0,07 
LA47 p3 day 2 C - - 23,25 0,01 22,68 0,04 - - 28,26 0,04 28,72 0,09 
LA47 p3 day 5 C - - 23,66 0,02 22,77 0,09 37,63 0,01 28,67 0,01 29,31 0,03 
LA47 p3 day 14 C - - 23,38 0,07 22,64 0,01 - - 28,91 0,06 29,01 0,06 
Genes ADPQ B2M GAPDH perilipin PPARγ TBP 
Samples                      Values Ct sd Ct sd Ct sd Ct sd Ct sd Ct sd 
DF24 p24 day 0 - - 21,15 0,04 24,08 0,07 - - 30,31 0,05 29,54 0,48 
DF24 p24 day 2 AD - - 20,07 0,67 24,02 0,17 - - 28,79 0,13 30,58 0,40 
DF24 p24 day 5 AD - - 20,85 0,02 23,48 0,03 - - 28,63 0,06 30,36 0,19 
DF24 p24 day 7 AD - - 20,60 0,32 23,42 0,10 36,93 0,14 27,50 0,29 29,94 0,01 
DF24 p24 day 14 AD - - 20,78 0,11 23,06 0,03 37,34 0,20 27,37 0,09 29,08 0,01 
DF24 p24 day 2 C - - 20,27 0,01 23,52 0,14 - - 29,39 0,21 29,83 0,04 
DF24 p24 day 5 C - - 20,28 0,03 23,84 0,00 - - 29,84 0,09 29,75 0,04 
DF24 p24 day 7 C - - 19,79 0,32 23,12 0,00 - - 29,06 0,01 28,90 0,04 
DF24 p24 day 14 C - - 19,76 0,02 23,22 0,01 - - 29,21 0,04 29,91 0,07 
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Genes ADPQ B2M GAPDH perilipin PPARγ TBP 
Samples                      Values Ct sd Ct Sd Ct sd Ct sd Ct sd Ct sd 
BM72 p6 d0 PBS - - 22,05 0 21,92 0,09 - - 31,81 0,04 28,20 0,10 
BM72 p6 d2 AD PBS 35,41 0,34 21,31 0,44 21,24 0,01 26,63 0,09 26,57 0,02 28,05 0,00 
BM72 p6 d5 AD PBS 34,73 0,03 23,22 0,17 22,72 0,07 31,90 0,12 28,45 0,05 29,86 0,11 
BM72 p6 d7 AD PBS 32,50 0,11 22,09 0,60 22,06 0,03 28,43 0,30 26,62 0,16 29,56 0,04 
BM72 p6 d14 AD PBS 30,12 0,10 23,12 0,06 21,65 0,45 28,59 0,10 27,07 0,10 30,39 0,10 
BM72 p6 d0 AD Col I - - 22,22 0,06 22,74 0,00 36,66 0,13 30,52 0,37 29,35 0,01 
BM72 p6 d2 AD Col I 35,90 0,56 21,35 0,13 19,94 0,03 29,12 0,39 26,69 0,26 28,48 0,07 
BM72 p6 d5 AD Col I 35,51 0,36 23,59 0,10 22,14 0,03 32,16 0,26 28,05 0,16 29,74 0,02 
BM72 p6 d7 AD Col I 30,07 0,11 22,10 0,13 21,71 0,17 27,05 0,01 25,62 0,02 28,17 0,39 
BM72 p6 d14 AD Col I 25,39 0,01 21,11 0,14 21,11 0,02 24,72 0,03 24,02 0,01 27,55 0,30 
BM72 p6 d0 AD Col IV - - 22,23 0,19 22,49 0,04 - - 32,01 0,29 29,15 0,05 
BM72 p6 d2 AD Col IV 35,09 0,33 21,17 0,16 21,23 0,01 27,09 0,03 26,37 0,08 27,71 0,02 
BM72 p6 d5 AD Col IV 33,89 0,08 22,05 0,01 21,45 0,20 30,73 0,24 27,06 0,18 29,28 0,01 
BM72 p6 d7 AD Col IV 31,84 0,02 21,46 0,25 20,94 0,27 28,19 0,02 25,87 0,33 28,57 0,03 
BM72 p6 d14 AD Col IV 30,54 0,08 23,29 0,20 22,28 0,38 29,27 0,20 26,18 0,43 30,33 0,25 
BM72 p6 d0 FN - - 22,40 0,64 22,87 0,04 36,89 0,14 31,01 0,42 29,35 0,10 
BM72 p6 d2 AD FN 36,34 0,13 21,56 0,25 20,39 0,01 29,72 0,04 26,90 0,13 28,56 0,12 
BM72 p6 d5 AD FN 34,65 0,81 23,64 0,03 23,31 0,25 32,04 0,35 28,16 0,77 30,61 0,32 
BM72 p6 d7 AD FN 28,57 0,07 21,36 0,02 20,93 0,01 25,82 0,12 24,86 0,01 27,74 0,01 
BM72 p6 d14 AD FN 24,40 0,01 21,29 0,33 21,05 0,04 24,02 0,02 23,53 0,06 27,64 0,02 
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Genes ADPQ B2M GAPDH perilipin PPARγ TBP 
Samples                      Values Ct sd Ct sd Ct sd Ct sd Ct sd Ct sd 
BM72 p6 d0 LN - - 21,92 0,19 21,66 0,04 - - 31,72 0,14 28,28 0,01 
BM72 p6 d2 AD LN 36,17 0,07 20,71 0,20 21,07 0,03 27,48 0,04 26,42 0,03 27,94 0,07 
BM72 p6 d5 AD LN 35,84 0,01 24,01 0,54 23,29 0,03 33,34 0,14 28,77 0,10 31,34 0,06 
BM72 p6 d7 AD LN 30,12 0,04 21,93 0,14 21,19 0,03 27,16 0,08 25,65 0,06 28,00 0,01 
BM72 p6 d14 AD LN 29,32 0,05 22,50 0,01 21,86 0,04 28,18 0,17 25,90 0,20 29,59 0,03 
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